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Studies in Childhood Tuberculosis 
Mark Patrick Nicol 
Childhood tuberculosis presents particular clinical challenges, two of which form the foci 
of this thesis. Firstly, establishing a diagnosis is frequently difficult as children are unable 
to expectorate, conventional microbiology is insensitive and the clinical presentation non-
specific. Consequently there has been interest in the potential diagnostic utility of novel 
interferon-gamma release assays, such as the enzyme-linked immunospot (EllS pot) 
assay. 
Secondly, the outcome of tuberculosis infection in children is diverse, with some 
infections progressing to severe, extra-pulmonary disease. The bacterial factors which 
inf1uence outcome are poorly understood, however there is increasing evidence of strain-
specific variation in virulence, with W-Beijing strains thought to be particularly virulent. 
Methods 
Part A. Two studies were conducted to investigate the potential utility of ELISpot for the 
diagnosis of active childhood tuberculosis. In the first study, chi ldren presenting to a 
tertiary care hospital with suspected tuberculosis were tested using an 'in-house' ELlSpot 
assay. In a subset, tests were repeated at I, 3 and 6 months. In the second study, the 
commercial T-SPOT.TB assay was used to test children at high risk for active 
tuberculosis in a community setting. 
Part B. All strains of Mycobacterium tuberculosis isolated from children presenting to 
Red Cross Children's Hospital from 2000-2003 were genotyped and the genotype was 
linked to clinical outcome. In addition, in order to investigate \vhether W-Beijing strains 
of tuberculosis were emerging in Cape Town, we genotyped tuberculosis strains in 
archived histological material from a 76-year period. 
Significant Findings and Conclusions 
Part A. The sensitivity of ELlS pot was 83% for the diagnosis of culture-confirmed 
tuberculosis in children presenting to hospital. ELlSpot values increased during early 
therapy and then declined. In the community, ELlSpot was less sensitive than tuberculin-
skin testing, particularly in very young children. ELlSpot may be useful as an adjunct to 
clinical diagnosis in children presenting to hospital, but should not be used to exclude 
disease in very young children. 
Part B. There was no clear relationship between broad strain lineage and clinical outcome 
however there was an association between the major sub-lineages ofW-Beijing strains 
and tuberculous meningitis. There was, however clear evidence from both paediatric and 
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Strains of Mlb from children in Cape Town are of interest for a number of reasons. 
Firstly, the Western Cape region represents an area of particularly intense tuberculosis 
transmission, with incidence rates approaching 1 % per annum(3;5). The reasons for this 
are as yet unclear and may relate to host or bacterial determinants. The area has lower 
prevalence rates of HI V infection than much of the country and yet a higher burden of 
tuberculosis(3). Since tuberculosis in children is classically primary disease, following 
soon after exposure to an adult infectious source case, strains causing tuberculosis in 
young children will tend to reflect those transmitted by adults in the same community. 
Secondly, since extra-pulmonary disease is frequent amongst children hospitalised with 
tuberculosis in Cape Town, this represents an important opportunity to study potential 
associations between strains and their ability to cause extra-pulmonary disease. Chapters 
5-7 detail a series of studies which were conducted to evaluate the association between 
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DNA or RNA have met with variable success(25-28), but appear to be highly operator 
dependent and prone to false-positive results due to cross-contamination(29). 
In most cases therefore, the diagnosis of tuberculosis is based the clinical and 
radiographic features of disease . However since the radiographic features of primary 
tuberculosis, such as hilar lymphadenopathy, may be subtle, radiography is unreliable(30) 
and subject to considerable inter-observer variability(31) . Similarly, the clinical features 
of tuberculosis in children are non-specific(7) . 
Since young chi Idren are at high risk of developing active tuberculosis in the period early 
followin g infection, a history of recent exposure to a case of active tuberculosis is 
important supporting evidence. The tuberculin skin test (TST) has, for decades, been used 
as a marker of infection with Mlb . The TST is performed by intradermal injection of 
purified protein derivative (PPO) of Mlb(32;33). The presence of delayed 
hypersensitivity to PPO is detected by the development of induration 48-72 hours 
following infection(34). Such a reaction is thought to correlate with sensitization to, and 
hence infection with, Mlb(34) . PPO is a complex mixture of proteins extracted from the 
whole tubercle bacillus . These proteins include many which are found in other members 
of the Mlb complex (including the vaccine strain iViycobaclerium bovis BCG) as well as 
environmental mycobacteria(35;36) . It is therefore likely that previous BCG vaccination 
or exposure to environmental mycobacteria may cross-sensitize to the PPO reagent(36), 
leading to false positive results and reduced specificity(35;37). Moreover, the ability to 
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Chapter 2 
Table 2. Studies evaluating the use of QuantiFERON assays for the diagnosis of L TBI in children 
Study Number of Assay TST Cut-off for TST Major findings 
participants (antigen) 
Brock et 125 children QuantiFERON-RD I Mantoux >\Omm 94% agreement (K 0.87) 
al( 49) and adults (equivalent to (2TU RT23) PPD affected by prior BCG I 
QuantiFERON-TB Gold vaccination, RD J not affected 
Connell 106 chi Idren QuantiFERON-TB Gold Mantoux > 15mm BCG vaccinated 69% agreement (K 0.3) 
et al(67) (IOTU, >5mm if known contact High rate offailed assays I 
I 
Cellestis) > I Omm all others 
Nakaoka 207 children QFGIT Mantoux ~IOmm 74% agreement (K 0.5 in high 
et al(68) (IOU [-STU], risk cases). QFGIT correlated 
Evans) better with exposure risk 
I 
Tsiouris 184 children QFGIT Mantoux ~lOll1m, or ~1 Omm TST: agreement 78.8% 
et al(69) (2TU RT23) ~15mm (K 0.56) ; ~ 15111111 TST: agreement I 
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Chapter 3. The enzyme-linked immunospot 
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Table 1. Clinical Classification of Cases 
Definite (n= 12) 
Case Isolation of kitb in culture (sputum, gastric aspirate or cerebrospinal fluid) 
Probable Must fulfil all criteria in A, B, C or D below 
Case A. (n=IS) 
Symptoms consistent with TB 
Known close contact with TB patient 
Mantoux skin test ;::10 mm AND abnormal Chest Radiograph 
B. (n=20) 
Symptoms consistent with TB 
No known close contact with TB patient 
Mantollx skin test ;::10 mm AND abnormal Chest Radiograph 
C. (n=6) 
Symptoms consistent with TB 
Known close contact with TB patient 
Mantollx skin test ;::10 mm OR abnormal Chest Radiograph 
D. (n=6) 
Symptoms consistent with TB 
AND ONE OF: 
Gastric aspirate smear positive (n=l) 
Cerebrospinal fluid and cranial CT consistent with tuberculous meningitis 
(n=4) 
Abdominal ultrasound and CT suggestive ofTB abdomen and response to 
therapy (n= l) 
Possible (n= I I) 
Case Symptoms consistent with TB 
No known close contact with TB patient 













obtaining (YW"""",t Sml of blood was 
and processed within 2 hours. ELISpot (Figure 3.]) was performed as rI"c,,, ... !h,,,rI in 
A(S8). were enumerated by two observers a 
mean of the two nn" ... rvP'c" (mean inter-observer coefficient 
variation = 8%) both 




if> 10 spots/well 
of the background 
was based on 
value also corresponded with more than 2 




that in the test a 
33 spots/million 
The use ofthis value to 
reports by Lalvani et al(S2;S8). 
mean of the 
SD=8.S). 
were Comparisons between 
Kruskal-Wall i s test. chi-square test for trend was used to compare proportion of 
results by clinical category. The two-tailed Mann-Whitney test was to 
compare unpaired results time point) the Wilcoxon signed rank test for paired 
observations and 1 month). test was for of responses 










Figure 3.1 The ELISpot Method 
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A total children age range 3-154 with a of 
tuberculosis were 12 children were assigned as definite 
cases of tuberculosis, as probable and 11 as iJ~C'""V'~ cases I). A sequential sub-
group had repeat assays I month. sub-group, 25 children in 
follow-up was possible were retested at 3 months 10 at 6 Of the 
healthy children who were contacts adults tuberculosis, 1 
TST (Omm) and the remaining 12 had 5mm. had a TST ,",Pt'mp,'" Omm and 
3.3.1. Responses to ESAT-6, and at diagnosis 
The distribution responses to CFP-IO and PPD diagnostic _~ .. ",..,_. at 
diagnosis is shown in 3.2 There was a non-significant trend median 
(p=0.063 I) and 10 (p=O.l responses to lower in the probable and possible 
groups. Positive responses to either ESAT -6 or 10 were found in 10/12 
definite, (72.3%) probable 1 (45.5%) possible cases 3.77 
p=0.05). There was no difference between the median ages ofthose with 
and negative responses. was no correlation nf"'''ff''I'n response to PPD and 











Response to o (b) and PPD (c) by 
are means of two epi::llClerlt observers, given as 
corrected for background. A horizontal line is included to 
1000
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'-""""''''''"''''"' to PPD were higher in with positive 
or CFPI 0 (median 446 per million) than with negative responses to both 
(median = ] spots per million, p<O.OOOI, was no correlation 
hpl~u!f'pn response to any weight age Z score r=-0.070 
ESAT-6 718 CFPI0 1721 p=O.l 
Figure 3.3 Ke:SPCms(;s to PPD at diagnosis those with compared with 
positive responses to O. Results are means oftwo maemma,em 










Agreement between and in children with a 
clinical diagnosis of tuberculosis 
TST 1" ... rrnp/'1 part of the algorithm, it was not possible to compare the 
utility and as a diagnostic except in children with culture-
confirmed tuberculosis. In group, was positive in 617 children (compared 
10/12 for ELI Spot). there was poor "''''''''''11' between 
TST 
TST 
ELISpot (69%, 0.04), with a 
a ELISpot (Table 
proportion with a 
Table 2. Comparison and ELISpot in children with Iy defined 
TST (Mantoux .:::10mm) 
Positive Nt:g<lUvt; Total 
Positive 39 I 40 
ELISpot Negative 17 1 18 














3.3.3. Responses to ESAT-6, CFP-IO and 
treatment 
Chapter 3 
after 1 month 
Repeat testing was performed at 1 month in 42 subjects. cases were 
as 
responses are 
1 month (419 
was no significant 
(58 and 
6 as probable and 27 as The acute and 1 month 
in 
between acute and 1 month 
per million) or 10(57 
in median response to 
per million). Acute and 
I month 
ESAT-6 
were highly forCFP-lO r= p<O.OOO 1) and 
r 0.6289, p<O.OOO 1). 
1 month trp"h"p.nt median responses to CFPIO PPD were 
between diagnostic groups (Kruskal-Wallis p=O.0133, 18 p=O.0079 
higher responses amongst probable when with respectively) with 
possible cases. 
those in the VV""'UI 
was a trend responses in definite group to be higher than 
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Responses to ESAT-6, CFP-IO and PPD after 3 6 months 
of 
reSIPOl1lSeS were cuucu,",u In a r"t'''PI~nT1 
responses to and o is 
to these antigens at I month was followed by a 
p=O.002, 1, CFPI 0: p=O.002). 
to ESAT -6 were significantly higher 
3 months (Kruskat-Wallis p=0.0406). 
responses to 10 and than IJV""..lJ. 
(Kruskal-Wallis 1097 for 
10 patients. The evo.lution of 
An initial rise in response 
at 3 and 6 months 'VU'H~'" test 
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3.5 Responses to o and PPD during the course Results 
are means of two independent on',Pl"vP"" given as spots per PBMC, f'Ar"t"Pf'tprj for 
IblCFP10 
1250 
Months Qftharapy Months of therapy 
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3.3.5. Responses amongst healthy childhood 
Responses to CFPIO PPD (Figure were strikingly amongst 
tests (p<O.OOOl for Only two a 
negative test had a response to and none to 10. A 
of 100 spots per million to PPD discriminated between TST-positive negative 
individuals in all cases. Only 1 child with a TST> 15mm had a negative to 
ESAT-6 2 had responses to O. 
3.6 to PPD, CFPIO healthy contacts 
of adults tuberculosis. are means of two independent observers, as 
per million PBMC, rnrrp{"Prl for background, represent responses. 
from children ofOmm are on left and with TST of 
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o in a 
group of children with a clinical diagnosis have 
a number of implications for the use 
and monitoring of tuberculosis in childhood. 
3.4.1. Sensitivity of ELISpot for ............ . 
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It is clear that a prop0l1ion 
negative ELI Spot 















the clinical diagnosis 
diagnosis were found amlongst 
(83.3%) cases. The 
confirmed tuberculosis 
Liebeschuetz et a1 (81%)(70). 
with negative responses to 
responses at] 3 
subset may well 
6 
diagnosis of tuberculosis may 
in children, or both. Of note, positive responses at 
possible (45.5%) than probable (72.3%) or 
for ELI Spot for the diagnosis of 
coincides closely with that found by 
observation that those children in the 
o at diagnosis 
responses to 
with a diagnosis other than 




effects of therapy. 
the expense, prolonged duration and 
hypothesis will remain difficult to rove, the difficulty in 
confirming in as no appropriate 'gold-standard' 
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with] month. 
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However 6 a positive response to at least one at the one month visit, 
tuberculosis. Only 1 of 
responses at I month. 
tests at ] month might be a useful 
but not at including one child with 
the 9 with culture proven disease had 
borderline or 


















and ELISpot responses 
was poor, a 
TST. 
for finding. Firstly, this may be due to 
of childhood tuberculosis. This is difficult to assess in this 
of having 
group of 
children with culture-confirmed tuberculosis is smalL Alternatively, may llV"""",,, 
speeificity, with resulting from BCG vaccination or 
sensitization environmental m)ICODa(~tel this study did not include a large 
group with a we are unable to this 
possibility. The will this issue 
therapy 
There was no 
o or ESAT-6 at 
were significantly 
this 
in magnitude of ELISpot responses during 
difference "'PTUTP'>" the magnitudes responses to either 
compared with one month. In PPD 










response to The on responses 
to documented a transient 
ofMtb in response to 
persons. In contrast, shown no 
TSTon responses to and o. 
Wilkinson et al(77) have that the ratio of ESA T -6/PPD cells 
in central compartments is than that in 





Such IlP"tro,h"", during active 
by 
account for the 
Finally, severe TB has been ass;oclat<::a with production by 
PBMe, in a prop0l1ion ofTB The recovery antigen-specific 
during therapy has previously been shown to be antigen dependent(79), which could 
In 
account the differences between and RDI-encoded in this regard. 
It has previously shown that EUSpot responses to PPO are unable to 
distinguish prior vaccination and to tuberculosis(35). The 
to at diagnosis were significantly 111 group who 
to either of the antigens compared with those who did not. PPD 
responses were in almost all children however, there was considerable 












No threshold for corresponded with a positive response to 
antigens. 
has demonstrated the disappearance of responses in patients who 
responded to three months oftherapy, but responses in who 
therapy. Sequential been as a biomarker of successful 
In our an increase in visit was 
in 45% (ESAT-6), 40% (CFP-IO) and 69% (PPD) and 
cases. This against the use of an early in ELISpot responses as a 
for successful treatment. Results amongst the J 0 cases in whom 3 and 6 month 
data were available suggest that an early in responses to PPD and at 1 month 
is followed by a decline in responses 3 and 6 months to a level similar to that seen at 
presentation. 
3.4.4. Responses amongst healthy contacts 
toPPD between 
Healthy TST-positive children had similar responses to with active tuberculosis. 
presumabJy uninfected) healthy children had responses to the 
specific in 12114 cases. 
nT"·,..t~·r1 with tuberculosis, 
latent or sub-clinical 
is unable to 
to be useful in 











3.4.5. Limitations of this study 
This study was to document responses in ldren with a cUn ical 
whose diagnosis at imperfect. 
those in 
acknowledge a 
of the study, group, 
may have an alternative Indeed, the likelihood of over-diagnosis of childhood 
tuberculosis is an important conclusion ofthis study. did not intend to conduct an 
of ELI Spot as a diagnostic tool, but rather, to document responses children 
_._,., ... ,~.~ oftuberculosis. We that these data that ELISpot 
formal evaluation as a 
repeat test at I month, and 






tool childhood tuberculosis, with a' 




















ESAT-6 or CFPlO-specific interferon-y-producing nr\f'UTI'C were ael:eCI[a at 
in two thirds of children presenting with a diagnosis of tuberculosis, 
however responses were more frequently in those with culture-proven disease. 
I month a however median "",-,VB"'"''' to PPD 
were to the 
is a promising tool the month and then 
evaluation of children "",,,,,,Ui!', to hospital with suspected tuberculosis where it may 












Chapter 4. The utility ofT-SPOT.TB for the 














Since nor are able to infection, 
in practice a result in a child with " .. ",,,,,,,,,n.,,,-, tuberculosis is non-specific for 
disease and may at best 
should a positive IGRA 
a result would 
to the diagnosis . .... "UIP"PI' 
for presence of 
in excluding 
Three prospective studies, 
specifically "'''''''UA''''.'''' 
our own, detailed in the previolls chapter, (12;50;70) 
utility of ELI Spot assays the of active 
81%-93% the 
diagnosis of A test with a sensitivity to 
widely acceptable to exclude infection in a Id presenting 
responses have been to 
in severe illness(80) since previous were predominately 
hospital-based that severely ill 1-""'''''''' were enrolled) it is feasible that the 
sensitivity·ofELISpot may be in children milder illness. We therefore 
to determine the sensitivity of ELI Spot in detecting tuberculosis in a community 
setting in who to their local health care facility with symptoms 













study was performed in the context large phase IV trial conducted by the South 
African Tuberculosis Vaccine which cOlmpan!d percutaneous and intradermal 
routes ofBCG (manuscript in nrf"n5'lr5'ltl study was In 
Worcester in the Western province This is a semi-rural 
population a high case "<lU"'--"" rate smear case 
rate: 60211 00 000 in 2004) and a relatively low HIV prevalence (prevalence 
antenatal clinic attendees: 8.1 % in 2005). 
the course of the study, 11680 BCG-vaccinated children were followed up 
for at least 2 years. for incident illnesses that could tuberculosis was 
over first 3 months were their vaccination 
visits at 6, 10 ]4 Over this period, the following 
were to a case verification at the 
tuberculosis hospital: who 
or with 
weight or to unexplained fever or 
had chest radiographs performed for respiratory 
to any of the hospitals 
of tuberculosis (loss 
(b) children who 
at any of the referral hospitals; 
(c) children who lived at same address as any adult case of tuberculosis 
over the All children YWPCPM,t. 
2005 were included in 
to the case verification ward 











from parents or guardians of all participants and the study was approved by the Research 
Ethics Committee of the University of Cape Town (REC Ref271/2000). 
The degree of exposure to tuberculosis amongst all participants was quantified by a 
history of contact with a patient with active tuberculosis. The non-exclusive exposure 
categories were stratified as follows: no contact, any contact with a patient with active 
tuberculosis, contact with an adult currently receiving anti-tuberculous therapy and 
contact with a household member with tuberculosis. 
All children were thoroughly investigated for tuberculosis including clinical exam ination, 
chest radiograph, acid fast microscopy and mycobacterial culture of 2 gastric aspirates 
and 2 induced sputa samples and a Mantoux skin test (2 tuberculin units ofPPD RT23, 
Statens Serum Institut, Copenhagen, read at 48 hours). A final diagnostic classification 
was assigned using an automated diagnostic algorithm (which did not include either TST 
or ELISpot result) drawn up by an expert clinical panel (Table 1). This algorithm is 
different from that used in the previous chapter, firstly since TST is specifically excluded 
(so that we could perform a direct comparison with T-SPOT.TB) and secondly since this 
cohort did not include any children with suspected extra-pulmonary tuberculosis. Chest 
radiographs were independently reviewed by 3 expert reviewers who were blind to 
clinical details, with a minimum of2/3 agreement required. According to the algorithm, 
children were classified as having definite, probable or possible tuberculosis, or not 
having tuberculosis. Maternal HIV exposure was diagnosed by antibody ELISA on 

















Chest X-Ray ~y,..,,,,v,,. • 
Chest 
not suggestive, 
Diagnosed as TB by treating 
clinician 
OR 
, Chest not 
• Not diagnosed as TB 
Chest X-Ray not SUI';ge;SU\le 
Not 
of tubercu 10sis cases 
1 or more additional featurest: 
2 weeks 
Failure to OR recent 
TB contact 
PLUS additional features (above) 
PLUS 2 or more additional 
(above) 
One or no 
4 
t Mantoux >= lOmm or positive T -SPOT.TB included as an additional feature on Iy when 












4.2.2. T.SPOT-TB Assay 
At the blood was col.1ected by peripheral venepuncture for T-
SPOT.TB, which was performed according to the manufacturer's (Appendix 
B). peripheral blood mononuclear cell (PBMC) 
Dickinson) were used to ml of blood from each 
were ","",..t,·rl to the laboratory 1 OOkm away in insulated and 
received within 5 hours of PBMCs were separated by centrifugation, 
""', ............. and ,-,v, ... ",,, x 1 were to of4 wells of the microtiter 
plate 'UH"HE> ESA T-6 10 (Panel A or B solution), or 
media only, After 16-20 hours of incubation, were washed, (,,£""''''',<1 
containing anti-IFN-y mAb added to each well and the plate "-"'V"'U"''','' for 60 
After additional washing, substrate solution was added and incubated a further 7 
minutes. Plates were then washed and dried enumeration spots by 2 ()h'opr\lp,'" 
a stereomicroscope. The mean spot count 
interpretation, A T-SPOT.TB assay was rpn"""", 
positive, the manufacturer's 
excluded if samples were received more than 5 
observers was used for 
panel 
T-SPOT.TB results were 
coHection, if the positive 
was 
control failed or ifthere were insufficient cells to perform the assay. 
Statistical considerations 
The outcomes were the of the and the of the reaction 












positive test was as ""'1-.1'1,0'" by For the Mantoux a transverse 
diameter induration greater or equal to ] Omm was Chi-
square test trend was used to test between the clinical classification 
and and TST as well as """-""'''''' degree of exposure T-SPOT.TB and 
approximation method was intervals for 
to compare ages np","lPl'M clinical Mann 
as I as time to sample 
used to com pare the proportion 
between 
exact test was 
exposure. 
and T-SPOT.TB. 
ofTST or number 
and age. 
4.3. Results 
with Chi-square was 
T-SPOT.TB tests to sample 
to determine the between TST or T-
kappa statistic was to summarize agreement 
test was the correlation 
on T-SPOT.TB as continuous 
A total of BCG-vaccinated children were had 
results (in 15 cases the T -SPOT.TB positive ""n~"A' failed and in 14 cases 
insufficient blood was 
hA."'''''·U more than 5 
was 18 months (IQR J 4-24 
and 24 months of age 
1;;I\;,-to;;;U after being received in or the specimen was 
collection, Figure 4.1). 
The majority 
median age ofthe children 











diagram of patient numbers and diagnostic 
Children with 
history 










0-12 30 9 (30) 
]3-24 131 56 
25-36 43 22 1) 
10 5 
Total 214 
* TST: tuberculin skin test 


















































a TST result 
a positive HlV child was included in 
tuberculosis with both T-SPOT.TB negative). 
responses is shown in 
histogram responses (all The distribution 
is shown. This follows a distribution with few children 
























4.3.1. T-SPOT.TB, and la2;no'SIS of active 
tuberculosis 
a positive T-SPOT.TB and a re~;ocms,e were strongly u,,,,v'''u'.''u 
likelihood of tuberculosis T-SPOT.TB and p<O.OOOl 
4.3A). 
"',run',, 4.3 
A. Proportion a (Mantoux:;: 1 Omm) or test 
clinical category. Both were more likely to be 
increasing clinical certainty 
B. Proportion of cases with a to a case 
of tuberculosis. were more 
exposure. (any: any contact with a case of tuberculosis; adult: contact 
tuberculosis; HVY"",UV a contact with active tuberculosis in the same JlVIU"",HVIU 
A 















Definite Probable Possible Not TB 
Chi-square test for trend: 
p=<O.0001 for TST 




TST _ T-SPOT.TB 
Any Adult Household 
Chi-square test for trend: 
p=O.0081 for 15T 











and TST responses were III 0 95% 
(80%,95% 49-94%) with culture-confirmed tuberculosis rp.<:np.c~n 
Chapter 4 
and 81l 0 
The 
of for clinically-defined 
categories of definite and was 40% (95% CI 
combined 
whilst 
was (95% CJ 3 of both when using 
the clinical category "Not "was 84% 
children positive TST T-SPOT.TB assays in 
m Of note, only 2 of the 113 children 
probable or possible tuberculosis 












cal:eg<ory A Mantoux test of 2: I Omm was regarded as a 
(TST: 
I Probable TB 
T-SPOT + TST + 
Possible TB (n=1 06) 














In order to determine whether the use ofT-SPOT.TB or TST would have substantially 
affected the diagnostic categorization of children, we compared the number of children in 
each diagnostic category when either TST or T-SPOT.TB was added as an additional 
feature to the diagnostic algorithm (Table 2, see footnote). There was excellent agreement 
between categorization of children using TST and T-SPOT.TB (93% agreement, 
kappa=O.902, p<O.OOOOl). The inclusion of either T-SPOT.TB or TST in the diagnostic 
algorithm would have resulted in the reclassification of 7 children from "Not 
tuberculosis" to possible tuberculosis in each case, however not all of the same children 
were reclassified using the two tests, so that including a positive result on either test 
would have resulted in 11 children being -reclassified. Neither test would have altered the 
diagnostic categorization of any of the children classified as having probable (or definite) 
tuberculosis. 
There was no significant association between anthropometric measures (z-scores for 
weight for age or height for age) and a positive T-SPOT.TB amongst children with 
definite and probable tuberculosis (data not shown). 
4.3.2. Association between the degree of exposure to a case of active 
tuberculosis and a positive T-SPOT.TB or TST test 
There was an increasing likelihood for T-SPOT.TB and TST to become positive with 
increasing exposure (p=O.0003 for T-SPOT.TB and p=O.0081 for TST; Figure 4.38). 
Similar numbers of children with no history of exposure had a positive TST (14/57, 












tuberculosis was significantly "rp'''''''n odds a positive (OR 
95% ] .2-4.8) but not a (OR I 95% .3). a positive 
and a positive T-SPOT.TB were significantly 
contact with tuberculosis 2.4 for 95% 1.4-4.2 for 
a household 
and 1.3-4.6 for T-
SPOT.TB). 
4.3.3. Association ... ",jr ... ",,,, ... age and T-SPOT.TB or TST 
children (.:::12 months) were more likely to a positive (40%, 
58%) a result (3%, CI <0.0001-18%). When considering 
only children with a history to tuberculosis, age did not appear to affect 
response but did affect T-SPOT.TB (children 2 months age were no more likely than 
children to have a positive TST [OR=0.83, 95% CI 0.34-2.02] but were more 
likely to have a negative T-SPOT.TB result [OR=10.04, CI1.31-77.05]). 
The proportion children having a T-SPOT.TB increased with age (Chi-
test for trend p<O.OOOl) whilst there was no such trend with TST There 
was a weak but correlation .... PTuIP'>n age and total 
cells in p=0.0065) but not age and diameter 











4.3.4. Effect of to sample processing on 
The time hPT'IXl",,>n collecting and processing did not affect T-SPOT.TB results, 
with no when by 
number of hours to 
in the proportion of positive 
(p=0.5276). The median to nnw",-",", "'''~''H'''>M T-
(3.5 hours) and (3.6 (p=0.319). 
there was no in median time to assays a 
control II hours) and without (3.4 15). 
Discussion 
The most important finding was that nor TST could 
to exclude the diagnosis of tuberculosis in children in a vv, .... ,'u setting. 
Our results, which showed that T-SPOT.TB only 5110 definite cases 
with 8/10 for and 40% definite or probable cases (compared with 52% for 
with of Liebe schuetz et al who a sensitivity 85% for 
children admitted to hospital 
confirmed or highly probable tuberculosis at "Y>r,"",.· study site in South Africa(70). A 
and 70% for , amongst 
""''''J ..... study, conducted in a hospital in a low prevalence country reported a sensitivity 
of for the diagnosis of tuberculosis in children with established culture-proven 
disease(50). Whilst the clinical algorithm used in study may over-diagnosed 
tuberculosis probable cases, the proportion of responses in 
the definite (50%) and probable (37.5%) categories was similar, suggesting that 












The inclusion of either T or TST both) in algorithm In 
study would not have V"M''''''''~ diagnostic categc)n;~atl of of the children 
af\"'7P'rI as having Only 2/164 children classified as 
probable or "~~0'~'_ tuberculosis had a negative TST and a positive 
so the use -SPOT.TB in place in add ition to would not have 
improved the diagnostic yield. 
T-SPOT not appear to any m over TST for 
the diagnosis What are the possible reasons for poor 
of in this study, when compared to previously published work? 
The potential explanation to patients studied. Previous studies have 
examined children to hospital suspected tuberculosis, we also 
children who attended their local clinic with symptoms 
tuberculosis or with a history of contact a patient with These children 
may had milder or earlier than in studies. It is feasible that very 
presentation might "'rp{,prlp development 
responses (which are u,"",,,,, .. ,,,,,u the assay). !-IfY,,!p',!pr the TST was positive 
in 3 of the 5 cases of culture confirmed tuberculosis who had a 
assay, at m 
difference tests may arise 
TST response to Mtb in 


















a recall response to ESAT-6 and CFP-I0 in 
BCG. 
same way as 
Secondly, we used commercial assay in this study. In previous 
chapter, we demonstrated that an in-house EUSpot using recombinant 
10 proteins had a sensitivity of 83% the of 
tuberculosis in 2). The prospective study with 
and 
both recombinant as well as overlapping peptides 
from and 10(70). In contrast, the commercial assay 
uses only of overlapping peptides derived from these The 
V"'_"""l~ and presentation associated with peptide and recombinant antigens 
may influence responses, nr>,,,,,''',;pr since do not V"',""I"l~ this 
perhaps to favour the commercial On the hand, possible pvt""f"pi 
antigen(81), may favour the recombinant 
final to possible age dependency but not 
responses. The median age children in study (18 months) was markedly lower than 
m months). Whilst coJ1eagues(70) did 
not find an "'PT"V,,"'>" age and EUSpot responses in their may 
with due to small numbers in the younger age group (the median age 
and probable 
study, was a clear trend for 
n('r'Pl'I<:p with age. There was no 
was 50 














" .. ",Tn,'po this is to simply rpn,rp<:P"t an in cumulative exposure to 
when considering with The aSS<)Cultl was 
children of 12 months of age and younger who been exposed to a tuberculosis case, 
A of studies an association between age and production in 
response to mitogen and mycobacterial in the whole model, 
that may playa 
It may that the "rn,,,,,_,,pn was for relatively 
high proportion of young children with a positive compared with T-SPOT. 
is a difficult to resolve, it appears from strongly 
distribution responses, with TST between 0 ] Omm, that if 
does prime TST 
range vVl""'VI 
in this community, that 
BCG vaccination of 
responses are In 
Jt seems more 
plausible the strongly positive responses which were seen were result true 
the ofT-SPOT and TSTwere 
(84%) in group of children clinically as not having tuberculosis, 
that BCG did not playa major role in priming a TST response. 
Whilst not 
SPOT.TB both 
outcome study, it is interesting to note that TST and T-
to tuberculosis. A 
(but not T-SPOT.TB) was with a history of any to tuberculosis, 
whilst both a positive TST and were associated a history of 










sensitive marker infection 
is more 
colleagues who concluded that 
recent IUU'I..;II.,U infection 
4.5. Conclusion 
shown that a substantial 
m children, or alternatively that T-
"''''''',IJUJ'''' with the findings of H ill and 
than TST the 
in the Gambia(66). 
young children with clinical 
microbiological evidence oftuberculosis have a negative response at 
:un""" .... algorithm would not The ......... , .. ~, to a clinical 
the sensitivity of this algorithm. The test should interpreted with 











Part B. Studies of the clinical implications 













Chapter The clinical implications of strain 













The previous chapters 
in childhood 
described 
diagnosis in young children. The second 
conducted to one important 
of this 
difficulty in confirming 
will explore a 
but one which is similar concern 
the high "'H.''''''~'''' of severe 
clinicians who treat children with 
of tuberculosis, including ");:"~HI11'''l'''U and 
extra-pulmonary disease amongst children. age clearly an important In 
influencing the outcome infection, potential role of 
variation in this topic two 
work we have conducted to 
strain III 
Introduction 
Mtb is an 
thought to be 
One world's population is 
"""v',",'U. with up to 9 million cases of active UI"',","":'''' worldwide every 
). A hallmark of the history oftuberculosis is the outcome of 
infection with Mtb. Following exposure to a case 
will show immunological 
intensity exposure, the sputum 
infection(84). may to the and 
load the source case the possibility 
innate Of to 
2 billion worldwide), it is estimated 
immunosuppression, only 10% will ever develop The manifestations of 
itself are ranging self-limited pulmonary to localized extra-











outcomes remain incompletely but may to variation in both the host 
pathogen. An appreciation of the inherited and acquired host factors that 
mycobacterial infection has advanced our understanding of mechanisms of protective 
immunity. of such factors single gene defects the 
interferon-y / interleukin-12 which predispose to severe non-tuberculous 
infection(85-87), 
with therapeutic blockade of tumour necrosis factor by monoclonal antibodies used for 
rheumatoid arthritis and Crohn's disease(88) the profound increase in the 
new infection with the cellular 
COJ!lSeQUIem from l-IlV infection(89}. It remains 
host immunological may playa 
tuberculosis in the population(90). 
IS 
in many 
that genetic variation in 
infectious conditions, "-w""",,, 
n'>l"""llPr to what extent more 
III susceptibility to 
bacillus may also playa role. 
in the is a 
determinant outcome. presence of toxin-encoding genes in staphylococci and 






ancestor of Mtb is 
IJnf~Un'I{}YlIl.Je are important examples, many and ;'lr,pnf,nf'n 
amongst bacterial to the presence of 
virulence determinants. In contrast, whilst the 
to have been an organism was to 










of Mtb is the inabUity of these to undergo lateral 
although evidence rare events recently described(93 ). 
V"~'~U<U'F," of genetic material is rare, Mtb evolves primarily by deletion and 
duplication events. One important of solitary is a 
strains, 
a common ancestor with no of lateral exchange of genetic 
material between lineages. A natural consequence might be the 
of pathogenic these 
5.2. Defining strain diversity in Mycobacterium 
tuberculosis 
Any understanding the implications of in Mtb must start with an 
appreciation of the nature such and lineages to be clearly 
defined in to compare their behaviour. 
The inability of Mtb to exchange material might predicted to III 
diversity. Initial reports "UF;F,,,,.;a,,, .... that this was indeed the case, with a 
low frequency of single nucleotide polymorphisms (SNPs) 26 structural 
genes in a representative collection strains(95). However, subsequently evidence 
f-'rnt'rL'"'' of considerable diversity within Mtb. This diversity takes the form of 
SNPs as well as deletion, duplication and events. Filliol et describe high 













in compJete linkage SNP occur LV!';",."",. more 
than be expected chance), supporting the clonal nature of Mtb 
Their analysis defined 6 phylogenetically distinct with strong 
associations .... "'Tn'''''' ... " .. _ •• ,...,_ and origin of the 
The sequence 10 been shown to be an important contributor to the 
generation of genetic diversity in Mtb. 1S611 0 may insert into genes, disrupting the 
deletions events and 
gene expressIOn activity(97). 
For many years, our appreciation phylogenetic relationships between strains of Mtb 
has restricted by use of limited measures of l';"""'''''"' variatiOll. The standard 
genotyping instrument for has 10 restriction length 
polymorphism (RFLP) analysis. This is an for epidemiological 
Iflllfl<lllUI"Y but is not necessarily best suited for it is highly 
rates transposition and a 





















such as spoJigotyping(99) multiple 
(MIR U)( 100; 1 01) analysis have offered a more 
not necessarily more suited to phylogenetic 
Spoligotyping is based on polymorphism in the direct 
chromosome. At this locus, there is a 
interspersed by each 
Mtb 
are 
or absence of43 spacer regions is 
are amplified 
a reverse dot 




primers directed at the 
m",,,"n"tc are then hybridized to 
the bound detl~Cti;:d by 




an international "'w,«"'"'''''' and of consistency to 
naming of the major lineages of Mtb(102;1 03). I\/lnt'pn\!;>,. there is a high degree of 
consistency in the identification major lineages between 
sequence polymorphism and single nucleotide polymorphism analysis(96). 
However, in spoligotype may occur due to single deletion 
is not always useful 
discriminatory to 
relationship between strains, nor is it sufficiently 
closely strains(104). It is therefore 
epidemiological investigations where it is important to differentiate between 













ofMtb contains repetitive 40-100 pair sequence as 
'mycobacterial interspersed units' (MIRU) which are found as tandem repeats 
at loci throughout chromosome(lOO). loci demonstrate 
hypervariability in the number repeats, leading to the use of the term number 
of tandem (VNTR). 
The typing method is on the detection of the number of tandem 
I'"r,p<;>r" present at several different 
loci. MIRU-VNTR is n"'~TA~lY1 
of the amplicon and hence the 
The most commonly 
amplifYing locus 
method ~"~'''U''Vv ] 2 
determining 
combined into a 
sp01 igotyping(] 05), 
code. 
appropriate phylogenetic 
of at locus(100). are then 
technique is more discriminatory than 
loci are ass.ess;ed. may more 
However it is less visually intuitive 
spoligotyping, more labour intensive and not always concord well with SNP-based 
phylogenetic analysis(96). may to potential for or loss at 
each locus, to possibility of convergent evolution (broadly different strains 
acquiring similar numbers of repeats at a particular locus). More recently, an updated] 5-
10CllS MIRU-VNTR protocol has 
o RFLP( J 06; I 
proposed and shown to as discriminatory as 
of the important mechanisms which geIlerlC diversity In is through 
chromosomal deletions. Such sequence polymorphisms 












is rare, all of a parent strain will carry same deletion. 
presence or of these deletions is used to major within Mtb. This 
approach infers a basic structure to the evolutionary tree by the 
acquisition of deletions. It is useful for "''''':lUll'''' 
with spoJigotype or RFLP patterns. 
that those strains of Mtb 
lineages and do not represent 
have been sequenced 
clonal relationships amongst 
technique has been used to show 
in two related 'modern' 
global diversity of strains(94). 
The most method, """,>t""""''' the global of Mtb, is the use of 
Mtb into 3 principal h'"L~L''' used to 
of the gene and codon 95 gyrA 
broad phylogeny 
analysis will advance 
for many years. The 
understanding. 
in a restricted was 
on III 
tree defined 
of recent more extensive SNP 
and col'"''''., ..... .." 11) have 
463 
90 genes in 1 04 globally representative strains to define the relationships between 
major 
diversity in 
of Mtb. This is an important forward in defining the nature of 
and offers an ideal starting point 
of such diversity. The application relatively low 
technology to multiple representative strains 
of the extent of 




evaluating the cJinical implications 
throughput 
may significantly our 
as well as the relationships 











Finally, the region Mtb the gene 
families has shown to an important source of genetic variation(17). In particular, 
it that this region partly responsible for variation in 
Mtb, which could feasibly be a mechanism immune evasion. 
Figure Schematic rpr,rp'OP11,t!>t M tuberculosis genome, indicating 
basis of genotyping techniques. The circular chromosome of the rpte> ... ," 
H37Rv is shown together with examples of the major !".""''''''''' elements used strain 
For only one MIRV 
one IS6110 
polymorphism are shown. 
At each MIRU locus (12 or 15 
different loci are commonty used) a 
variable number of tandem repeats 
are found. The number of repeats at 
each locus defines the MIRU 
genotype 
Direct repeat region with identical DR 
s,","1Jer.ces and unique intervening spacers; 
presence or absence of each spacer 1-




interspersed repetitive unit) locus, 
TTA .. A.'''P (RD) one nucleotide 
polymorphisms (deletions), denoted 
difference, are variably in the TB 
genome and may be detected by analysis 
Single nucleotide polymorphisms consist 
of a single base here 
The insertion sequence IS6110 (flanked 
by inverted may insert at 
various sites in the genome. The 
IS6110 presence of these sequences is 











Table L Comparison of techniques 
withinMtb 
IS6110 
Discriminatory Excellent Fair to poor 
power 








Interpretation Simple, but not visual 
easily interpretation 
standardized 
Data sha ring Complex, lack 
of standardized 
sl amlard ized binary 01' octal 
nomenclature 
Utility for Excellent due Useful for rapid 
epidemiological to high cluster 
investigations discriminatory identification but 
power 
contlrmation 
Utility for May be limited Fairly good 
phylogenetic by correlation with 
analysis ratcs of SNP-bascd 
transposition phylogeny. Large 
and favoured deletions may 
sites. bias analysis 
Chapter 5 
or evaluating genetic diversity 
MIRU-VNTRt LSP analysist SNP§ analysis 
Good to excellent Poor Poor, likely to 
(newer improve with 
increased SNP 
identitication 
Simple and Rapid and fairly 
robust simple; high 
throughput 
access [0 analysis requires 
sophisticated access to 
equipment; can be 
perlormed on equipment 
heat-killed 
cultures. 
Simple visu l Straightforward 
interpretation 
Straightforward, Straightforward, 
standardized standardized standardized 
numerical coding nomenclature nomenclature 
Excellent and Poor due to low Poor at present 
rapid with newer discriminatory due to low 
protocols power discriminatory 
power 
Relatively poor Useful for Gold-standard: 
correlation with evolutionary low rate ofSNP 


















* length polymorphism 
t interspersed repetitive unit-variable number repeat 
polymorphism 
§ po I ymorphi sm 
clinical outcomes 
Just as any to link strain diversity and clinical outcome on a robust 
definition strain genotype, it also relies on the ability to a spectrum of 
clinical outcomes. complex natural clinical history lead to the use 
ofa measures of virulence, including the number infections 
an index case( 112), the ratio of active to latent infections( 15), the propensity to 
cause 13) and the ability to or to cause extra-pulmonary 
measures may affected by the 
of appropriate therapy. Due to in defining appropriate 
. 
the influence of non-strain as host immunity and the 
on outcome, much of the ,.u" ...... "F> the relevance strain 
in tuberculosis is based on experimental models or the use of laboratory 
mutants Whilst these studies have done much to advance our understanding of 
the of tuberculosis, they have "'"I'lfl''''' limited insight into the clinical 












5.4. Lessons from outbreak strains 
OUf understanding of the implications of strain diversity derives largeJy from work 
describing strains ofMtb responsible for outbreaks in the United States and the United 
Kingdom. The first well-described outbreak strain, CDC 155] l caused a large number of 
tuberculosis infections, including 2] cases of active tuberculosis in a small rural 
community between 1994 and 1996(115). The high rate of transmission to contacts (72% 
of contacts had a positive tuberculin skin test) was considered unusual. The initial report 
also described enhanced virulence in mice, with more rapid early growth than a 
comparator laboratory strain (Erdman). Subsequent reports, however, suggested that this 
strain was no more virulent in mice than other comparator strains, including the 
laboratory reference strain H37Rv as well as two clinical strains(l ] 6), but induced a rapid 
and robust pro-inflammatory immune response in mononuclear phagocytes that may be 
related to the high rate of tuberculin skin test conversion amongst contacts. In contrast, 
Anderson and colleagues describe an outbreak in the United Kingdom, due to a strain of 
Mtb that appeared to inhibit the development of a positive skin test amongst those 
infected, possibly due to the suppression of prointlammatory tumour necrosis factor and 
interleukin-12p40 production(l17). The mechanisms whereby these strains differentially 
induce pro-inflammatory responses remain unknown as does the mechanism relating the 
tuberculin skin test to the magnitude of in vitro cytokine responses. 
A third strain, HN878 (a member of the W-8eijing lineage of strains), caused several 
outbreaks of tuberculosis in Houston, Texas between 1995 and 1998 (although the 












to cause rapid death in immune 
dissemination, more severe clinical 
mice(18) as well as increased 
and bacillary loads in a rabbit 
meningitis model(l9). The attributed to 
to suppress pro-inflammatory "'rEV"'I'1",n" of a 
such as tumour and 6. PGL production 
is dependent on the presence of a polyketide gene, which is intact in the 
of W -Beijing strains, but interrupted by a many strain families. 
of synthesis resulted in attenuation 
was to induce a strong early Thl response that was rapidly 
HN878 
by the 





to active infection within one year. 
comparator strains to acid and 
in its ability to replicate in human 
macro phages expressed and secreted less protective 
more interleukin-IO. This ability to subvert 




confirm that the pattern 
of tuberculosis strains. It will be important to 














from these studies is of variable induction ofhost 
by clinical strains from different genetic backgrounds. In 
Th I responses (here interleukin-I 0 production is 
appears to be an important 
extent to which this is 
A question which remains 
at in 
characteristics are features 
level of strain 
or whether 
Do Mycobacterium tuberculosis 
their pathogenic potential? 
differ in 
virulence Perhaps the first clues that there may 
from the work of Mitch is on and "'-"F;U"':>, who 
from South Indian and British patients in the 
isolates were attenuated in a number 
assessment of bacterial burden and rate 
third of the Indian 
were markedly 
tools were not 
Indian 
one 
cultures and one third 
only. Since modern genotyping 
whether these early observations were 
""'""-" .... 0.'" experiments have never been 










that strains of differing 
9;1 models. 
of the most widely described strain 
128) whose members have 
As the name suggests, 
account 
of W -Beijing 
Latvia(134), 
with multidrug- resistance. 
strains are highly virulent, 
9) and early death(l8), 
described is 
virulence in mice(1 
... _~,..".v worldwide is the W-Beijing 
recognizable IS611 0 and spoligotype 
ate endemic in many parts of East 
for decades(129), are 
oftuberculosis(1 130). In 
in New York 31 ), 
Africa(136;1 is 
is clear evidence from animal ''''''""",.J 
bacillary load, increased 
from human is 
characterised member of the 
The extent to which the particular immunologic characteristics are 
amongst other W-Beijing 
glycolipid is not universal amongst 
that a wide spectrum of 
are members of the 
remains unclear since the 
strains(l38). Reed et al 
strains all constitutively over-express genes 
regulon, including triacylglyceride 
accumulation of large quantities 
5 
One consequence is 











genes are not 
and are thought to 
authors hypothesize that the 
are 
to 
source during periods of nutrient CHII"'''lTlr\'' 
by 
Chapter 5 
oxide and low 
during latent 
may nrn""rIP an 
the potent host immune responses. This 
transmission and in 
finding is the first clear 
in vitro phenotypic characteristic which is broadly shared by the members 
a particular strain lineage. 





colleagues found that 
tJ"', .... ,,'.., with extra-pulmonary tuberculosis were three more likely to 
with strains, after correcting potential confounders(l J 4), although in 
or 
these was no evidence of such an ",""Vv'UII'V'H J 40). ]n Vietnam, W-Beijing 
been associated with treatment reJapse(141) and HIV 
another study, W-Beij with fever early 
This the a strain-specific association the 
contentious, 
of these strains to 
in the genes responsible for DNA 
148). An intriguing question is 
in frequency, with several 
treatment, particularly in 
"'PT',,,"'>" W -Beijing 
136;1 The 
was ascribed to a series 
however this has subsequently 
W-Beijing strains are pn1iPr,:nn 











]49-151). possible explanation the of these to 
the which, in protects poorly against challenge 
with a W-Beijing 152) and in confers poor protection against central 
nervous system infection with a W-Beijing 153;154). The widespread use 
vaccine therefore for the of 53). 
More evidence emerged that lineages may possess specific 
characteristics that have from long-standing interactions "''''.''''''''> ... particular 
and human populations. and 
broad 
San 
of Mtb which appeared to associated with 
to define 
host populations. In 
strains were more likely to humans 
corresponded with that of mycobacterial 
have adapted to The same has 
strain genetic background may 
HII'''''''''' as well as relative 
of particular resistance 
of drug-resistant strains(l56; 1 
5.6. Does clinical outcome correlate with a particular in 
vitro or genotypic characteristic of Mycobacterium 
tuberculosis 
Whilst there is emerging evidence that W-Beijing 
lineages in a number of important respects and 
are distinct many other 













Mtb is to 
are as no 
may also have 
This may however simply 
approach to the identification of 
the 
Chapter 5 
to support the notion 
but conserved 
In 
" .... ",,,,,.,r> virulence mechanisms in 
causing similar clinical outcomes and then attempt to define 
common in vitro characteristics amongst those strains which have 
recent transmission) have been as clusters of cases 






Similarly, strains from 
amongst more than one 
than non-transmitted control '''VH.''''''\ 
would intuitively "''',",V""J,'''''' 
an association between 
ofa gene 
60). It 
are found broadly 
with strains belonging to particular 
investigators have compared 
where was co-prevalent 
grew more rapidly in 
ability to replicate rapidly 
transmissibility. Talarico 
and the presence of deletions in the 
unknown function but possibly a 
in vitro and 
unrelated or whether are 
of strains responsible 
and pulmonary infection. Strains causing extra-pulmonary disease have 











phospholipase-C gene DO 62) belong to 'superfamil , based on 
analysis(163). Early """Art" that strains able to cause disease had fewer genomic 
deletions than strains 1J0n-cavitary 13) /,,\UI"''''''' not 
In summary, the evidence genetic variation may the outcome of 
strains have with remains fragmented and inconclusive. Isolated 
been I characterised some appear to similar immunosuppressive 
phenotypes. To what extent phenotypes are shared by belonging to broader 
or indeed, to clinical strains as a whole, is unknown. 
is the 
may characterised 
the relationship ,,,'r',,,,,,,>,, 
conduct rational studies to 
These will 
relationship Mtb and host. 





our ability to 
"""'HI""''' outcome and strain 
for a better "n"r .... ,"., 
which we conducted in Town, 
strains in order to improve our understanding 
relationship between clinical phenotype, 6 focuses on the 
relationship and extra-pulmonary 7we 
describe evidence indicates that W-Beijing strains are rapidly In 











Chapter 6 .. Distribution of strain families of 
Mycobacterium tuberculosis causing 
pulmonary and extra-pulmonary disease in 













One characteristic features oftuberculosis in children is 
range of clinical prt:selrltatIonS, from limited pulmonary or to severe 
As in Chapter 5, the 
determinants unknown. Host factors such as 
immaturity of the immune system and F'.""'''''''''' predisposition to infection are likely to 
diverse outcomes are 
playa role, however is result of a interplay host resistance 




in influencing outcome 
evidence ofMtb 
in vitro and in vivo( 1 These 
111 
Despite the that animal clearly demonstrate increased virulence of 
such as those of the W -Beij ing family( 18; 11 there is no clear evidence from 
human that certain strains or strain are more virulent than 
may be pal11y due to difficulties in U':>~''''':>OHj virulence in adult tuberculosis. A commonly 
used measure is the ratio of cases to latent infection{11 A more 
tangible and easily measured outcome is the proportion cases extrapulmonary 
infection by a particular strain or strain ... ".~"'~. children more frequently 
develop extra-pulmonary .... '.>va"v, childhood tuberculosis may be a useful model 
strain 
We reviewed typed all strains of Mtb from 285 children presenting to 












lineage with the ability to cause extra-pulmonary disease. Spoligotyping, 
mycobacterial ntprc"'Pr"",n repetitive unit variable number tandem repeat (MIRU-VNTR) 
typing sequence polymorphism analysis were these 
typing delineate the of 
strains into strain families an international 
6.2. Methods 
This was conducted at Red Memorial a paediatric 
referral hospital serving a large part metropolitan Cape Town. with suspected 
tuberculosis are referred to this """01'\11'" from peripheral and practitioners 
In to confirm the number of culture-confirmed cases represents a 
number tuberculosis in region. This is, in 
part, to the difficulty in culture children 
sputum or lavage are required). At present, these ", ... r,,,,,,",,,,, are confined to 
children. Therefor  almost all of the culture-confirmed cases of paediatric 
. 
in the region are made at one of two academic centers. The strain collection 
we includes all strains from one two centers. 
collected all isolates from children nr"cpy.1". to hospital over 
2000 to December . Culture confirmation of childhood tuberculosis 
difficulties in primary care and this culture therefore represents a 
proportion of the from children in served by this hospital. 












was whom an isolate was 
Research Ethics ~~'''''''''. University Town (Ref 320/2002). 
Genotyping was MP,"Y'r.,·,n,>l1 12-
locus MIRU-VNTR and sequence polymorphism (LSP) analysis. 
was performed as previously described (Appendix C)(99). MlRU-VNTR was performed 
a modification semi-automated method described by Supply et al(l 0]) on an 
100 A series peR 
reactions, each 3 MIRU 
The size fragments was an automated 
sequencer. The modification to the technique et al was as follows. For each 
reaction, ] in 70 diluted 0.2j.ll Genescan-2500 
standard or 000 size standard 
HiDi formam ide Biosystems) were for 2 minutes at 




in Appendix D. 
analysis was performed on strains 
set D. Analysis was npr'tArrn 
full protocol including 
on the basis 






W-Beijing family and the LAM3 (Latin-American-Mediterranean)/Flllineage. We used 











confirm that the LAM3/FJ J spoligotyping) is 
monophyletic a single l111, .. a"v} 
Tsolaki et al(J have previously that entitled of Difference 
(RD) RD150 and RDI may be to identify the w-
6.1). 
6.1 The sequential acquisition within the W-Beijing lineage. W-
Beijing are by the RD 1 05 deletion, whilst the other deletions 
sub-lineages as (from et al{l 09»). 
In order to RD142 we used a PCR .~a'''''',rI as previously 
109;109) RD150, 
two of primers were firstly a within the 
deleted secondly a encoding the 1 ribosomal 
Short were designed to specifically to the amplified 












EiptPl't",,,, of each product by PCR on an Applied 7000 sequence 
detection The """I.,""',," of probe is quenched by the presence 
quencher molecule also attached to the sequence. specific product is present the 
probe will 
probe occurs, 
to the product and 
in 
"'<"''''ITP of the If'<,,'''',,".,.. molecule the 
fluorescence which is automatically 
For each strain tested, amp Ufication 16S 
amplification control, the presence or abs:en(;e of the 
by fluorescence in a second channel, corresponding to the probe 
as a positive 
region was detected 
at the deleted 
RD18! we used PCR with flanking the of 
fol byagarose electrophoresis. presence a 17.12bp 
the RD181 had not deleted, a I OObp product confirmed the of the 
deletion F). 
Similarly, we designed an additional set of (Appendix to amplifY region of 
difference 761 (RD76 I ) in all strains. Our collaborator (Sebastien Institute for 
Systems Biology, Seattle) had previously AffYmetrix analysis(l to 
identify the presence RD in two rf>n!rp<:pntM 1 strains we 
supplied. We wished to deletion was unique to 
LAM3/F 11 strains. A 1371 product nEil,ro::tt,>Ei the of the whilst a 












6.2.1.1. and rvnnu·'nClnl.UrP 
Spoligotypes were represented in the Octal format as defined et al(165). The 
166) has now 
and spoligo) was 
(shared-type) designation in spoligotype 
(spoligo-international-type). Typing data 
former 
been 
entered an spreadsheet received an SIT (Spoligo-international-type) 
and VIT (MIRU-VNTR to 
after 
first 
by SpolDB4. was a fourth an international 
database project coordinated by the Institute Pasteur of Guadeloupe. 
is available for public at 
reconstruction was 1'\.,~·+r,..rrYI both by manual analysis 
a model that allows one 
for 
evolution of 
Applied Maths, Maarten-Latems, 
transition of either or MJRU 
a Maximum Parsimony network 
was performed linking spoligo-MIRU 
we 
by a single cha ge. network was constructed by first 
since the rate evolution of spoligotyping appears to be 
spoligotype 
than that of 
68). Intermediate alleles required to create a monophyletic network within a 
family were also visual display was using 
B ioLayout(l69). In addition, eBURST software was used for cluster W-












For analysis, cases with both pulmonary and were classified as 
having extra-pulmonary disease. effusion were categorised 
as having pulmonary disease. Fisher's exact test probability was used for contingency 
analyses. The Mann Whitney test was of median ages. 
6.3. Results 
Strains from a total 
where more than one 
strains were identical by typing 
tuberculosis accounted 47% 
extra-pulmonary lymph node 
were over the peri d. In 40 cases 
a single child, 
only once in the dataset. 
'JV''''''_U pulmonary disease for 46% 
for 7%. The most common manifestations 
extra-pulmonary 
(n= 12), peritoneal 
were meningitis (n=58), bone and joint 8), pericardial 
(with or without localized 
was 2 years, with 75% of than 5 











Table 1. age distribution 












Children with ,,,Vla.,-, ... lymph or bone and tuberculosis were significantly 
than with pulmonary disease (p=O.O 1 and 0.0187 T-IIV 
and/or PCR in children <18 months was "prTAr,..., when 
sus[)ectled (130 Amongst tested, HIV infection was documented in 13% 
of with isolated involvement of nodes; 20% with 
tubercu losis; 19% with tuberculosis. 
6.3.1. Comparison with the SpolDB4 
population structure 
Ofa total clinical genotyped both spoligotyping and 
122 different MIRU and 69 spoligotypes were A 
6 
,"'I'I,TVr\{> blot is shown in 6.2 and a representative MIRU-VNTR 











Figure 6.2 A representative spoligotype blot. Each strain is represented by a horizontal 
series of up to 43 spacers. The presence of each spacer (I to 43 running from left to right) 
is demonstrated by the presence of a spot on the film. The top row represents the positive 
control (H37Rv) and the second row the no template control. An example ofa W-Beijing 
strain (spacers 1-34 absent) is indicated by a filled arrow and a LAM31F 11 strain (spacers 












Figure 6.3 Analysis ofMIRU fragments using GeneScan software. The blue, black and 
green peaks indicate the amplified fragments for loci 4, 26 and 40. The Map Marker size 
standard is not shown for clarity. The size of the amplified fragments is denoted on the 
top axis. Small "stutter' peaks leading up to the larger blue and green peaks are shown 
(these are generated by slippage of the polymerase). The black peak has a green 
component due to spectral overlap of the green and yellow (represented as black) dyes. 
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iOOO l ~ 0 I 
Dye/Sample Minutes Size Peak Height Peak Area Data Point 
Peak 
7B, 1 10 ,34 246,16 3164 36107 3876 
7B, 2 12,55 321,17 7614 137398 4708 
7G,1 12,55 320,88 1578 4193 4705 
7G.2 12,57 321,55 1867 7824 4712 
7G, 3 12,88 332,75 1847 18761 4829 
7G.4 12,90 333,71 875 8421 4839 
7G. 5 14,33 384,71 1620 17586 5373 
7G,6 14,35 385,66 988 9901 5383 
7G, 7 14,86 403,52 6390 50478 5571 
7G, 8 15,73 435,42 1123 13086 5900 
7G.9 15,76 436,30 832 8096 5909 
7G,10 17,11 487,99 6694 115687 6416 
7Y,1 12,55 321,17 3768 23044 4708 
7V, 2 14,84 402,94 7083 58128 5565 












Spoligotyping identified II genotype families (nomenclature from the 4th International 
Spoligotype Database)(167), namely LAM3/FII (n=86), W-Beijing (n=70), X (IS6110-
RFLP European low-copy family) (n=30), S/F28 (n=21), Zimbabwean (n=7), other LAM 
(n=8), Tuscany and Russian (n= 12), Haarlem (n= II), T clade (n=20), CAS (Central 
Asian, n=5) and "unknown" clades (n= 15)( 170; 171). Except for the "unknown" clades, a 
parsimonious genetic network linking all alleles within their respective family was 
created using BioLayout software (Figure 6.4). 
6.3.2. Clustering analysis 
I f relevant clusters (historically or recently transmitted) are defined on the basis of 
perfectly identical MIRU- and spoligotyping alleles, a total of 27 clusters totaling 148 
clinical isolates were found (52% ofa1l the studied isolates). These clusters are detined 
by a combination ofa SIT and a VIT allele number (Table 2) . 
Eight clusters belonging to the W-Beijing (including one prevalent cluster of24 isolates) 
and five to the LAM3/F II family (including two prevalent clusters of32 and of 13 
isolates) were identified . Four clusters belonging to the previously defined S/F28 family 
and three to the previously defined IS6110-RFLP low-copy clade, also called the X 
family were found. Finally, five clusters belonging to more or less well phylo-













Figure 6.4 A maximum parsimony genetic network built for the five most frequent 
family genotypes (W-Beijing, LAM3IFII, S1F28, X-low copy, and Zimbabwe). 
Reconstruction was performed manually, using spoligotype to identify major families and 
then by linking SIT -VIT genotypes and allowing for creation of intermediate missing 
links when required. The size of the nodes reflects the number of strains with an identical 
SIT-VIT genotype, for clusters with more than 10 representatives . 
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Table 2. Clusters ofisoJates based on identical MIRU- and spoligotyping alleles 
Family designation* cluster VIT SIT 
number number number 
Central Europel I 220 
LAM3 2 236 
LAM3 3 213 
LAM4 4 249 
LAM3 5 213 
LAM3 6 213 
LAM3 7 213 
Russia I 8 140 
S 9 212 
S 10 250 
S 1 I 252 
S 12 262 
T3 13 257 
Tuscanyt 14 140 
W-Beijing 15 104 
W-Beijing 16 223 
W-Beijing 17 254 
W-Beijing IS 83 
W-Beijing 19 238 
W-Beijing 20 17 
W-Beijing 21 99 
W-Beijing 22 245 
Xl 23 112 
Xl 24 117 
Xl 25 258 
X3 25 ~4 
Z 26 237 






































































6.3.3. Correlation with clinical presentation 
Complete clinical records were available for review in 281 of the 285 cases. Of these, 52 
were known to have HIV co-infection and were analysed separately, since HIV infection 
is independently associated with extra-pul monary tuberculosis . Strai n fam il ies as groups 
did not appear to vary in their ability to cause extra-pulmonary disease in general or 
meningitis specifically. The proportion of cases of extra-pulmonary disease varied from 
50 to 70% between families, with children infected by the two largest families LAM3 and 
W-Beijing having extra-pulmonary disease in 46 and 50% of cases respectively. The 
clinical presentations associated with infection by the major strain families ofMtb are 
detailed in Table 3. 
Table 3. Site of disease amongst HTV -uninfected children classified according to strain 
family 
Strain Number Pulmonary Extra- Odds of Major extra-pulmona,·y disease sites 
family of only (0;', of pulmonary developing (% of total strains) 
strains family) (% of extra-
(%of family) pulmonary 




AIIHIV 229 101 (44) 128(56) 51 (22) 18 (8) 18 
neg (100 ) (8) 
LAM3/Fll 72 (31) 33 (4 6) 39 (54 ) 0.9 (o .n) J 6 (22) 4 (6) 6 
W-BeUing 52 (23) 26 (50) 26 (50) 0.74 (0 .3 4) 12 (23 ) 4 (8) 6 
X 24 (10) 9 (38) 15 (62) 1.36 (0 .52) 4 (16) 3 (1 3) 0 
S 19 (8) 7 (37) J 2 (63) 139 (0 .63) 6 (32) 3 (16) 0 
T 15 (7) 5 (33) 10(67) 1.63 (0.43) 6 (40) 0 (0) I 
Other 47 (21) 21 (45) 26 (55) 0.97 (I) 8 (17) 4 (9) ) 
* miliary disease frequently occurred together with localized disease at an extra-
pulmonary site 

























we and that this was 
to LAM3 
In we presence RD181, RDI and RDI42 in all 
150 181 ). 













Figure 6.5 Agarose gel electophoresis ofPCR products to detennine the presence ofthe 
RD761 deletion. A fragment size of 1371bp (lanes 5 and 9) indicates the absence of the 
deletion (non-LAM3) whilst a fragment size of277bp (lanes 1-4,6-8) indicates the 













Figure 6.6 Amplification plot of real time PCR to detect presence ofRD150 in 20 
strains. The top green and brown lines indicate amplified product for the RD150 region 
(in 16 strains), the blue and red lines indicate amplification of the 16S control (in all 20 
strains) whilst the bottom 4 lines indicate no product for RDI50 (i.e. these four strains 
had a deletion of the RD 150 region) 
L. '_ , _ , _ , _____ I _ ,-
RD150 present 
- -
, t ~9'r" 
I ~ ~ 
~ ~ ~ --~ ~, {I, .,,' 
16Scontrol 
) ~ 
~ ~ r 
- - ----.-~ f.- ==~ 
, ~ ~. V 
- - - - ~ - - ~ ,-- f- --V V - - -- - - V 





All but 2 of the W-Beijing strains studied had RDI81 deleted, whilst RD150 divided 
Cape Town W-Beijing strains into 2 major sub-lineages. These sub lineages coincided 
precisely with the eBURST cluster analysis of W-Beijing strains according to MlRU-












6.7 eBURST circle rf'nYf'<:,'n 
a are 
number in each the 
RD 150 not ",-,,,,,\.>u 












6.3.5. The relationship between sub-lineages of W-Beijing and 
clinical outcome 
Whilst W-Beijing strains were no more likely than other strain families to be associated 
with extra-pulmonary infection in our study, sub-lineages within the W-Beijing family 
were associated with distinct clinical outcomes. HIV-uninfected children infected with 
W-Beijing strains characterized by the deletion RD150 were more likely to have 
tuberculous meningitis (13/32) than those infected with W-Beijing strains in which 
RD 150 was not deleted (3/27, OR 5.47, 95% cr 1.36-22.03) . There was no difference 
between children intected with RD 150 deleted or non-deleted strains with regard to 
median age (30 vs. 25 months respectively, p=0.74) , drug-resistance of infecting strain 
(1 /32 vs. 3/27 respectively, OR 0.26, 95% CI 0.025-2.64) or place of residence (data not 
shown) . 
6.4. Discussion 
Strains of Altb from children in Cape Town are of interest for a number of reasons . 
Firstly. the Western Cape region represents an area of particularly intense tuberculosis 
transmission, with incidence rates approaching I % per annum( 172). The reasons for this 
are as yet unclear and may relate to host or bacterial determinants. The area has lower 
prevalence rates of HIV infection than much of the country and yet a higher burden of 
tuberculosis. Since tuberculosis in children is classically primary disease, following soon 
after exposure to an infectious adult source case, strains causing tuberculosis in young 












extra-pulmonary disease is frequent amongst children hospitalised with tuberculosis in 
Cape Town, this represents an important opportunity to study potential associations 
between strains and their ability to cause extra-pulmonary disease. 
The strain families circulating in a small precisely detined area of Cape Town have 
previously been well documented( 173-175), but there is little data regarding the broader 
Cape Town area. Since the referral area for Red Cross Children's Hospital encompasses a 
large part of Cape Town, our results may more generalJy represent this area. It is however 
possible that there is selective transmission of certain strains to children. In addition, if 
strains differ in their ability to cause severe or extra-pulmonary disease, then these may 
be over-represented in a collection from hospitalized children. We did not attempt to 
perform detailed evaluation of transmission patterns within the community. Warren and 
colleagues have previously used IS6110 RFLP to extensively address issues relating to 
strain transmission in a well-defined area of Cape Town(175-178). 
Our results concord with previous work of others( I 74) suggesting that two strain 
families , the LAM3/FII family of strains (32% of all clustered cases) and W-Beijing 
(J 7% of all clustered strains) predominate in the Western Cape. Taken together, these 
two lineages represent half of all the clustered isolates. Among the 27 VIT -SIT clusters, 
three (VITI 04SITJ , VIT213SIT33 and VIT213SIT719) are the most prevalent strains 
within this setting. The first of these belongs to the W-Beijing lineage and the other 2 to 
the LAM3/F J J lineage. This dominance may be due to ecological or historical factors or, 












addressed in the following chapter. These comparisons are helpful to better delineate the 
specificities of the local population structure ofM/b. Diversity within these families may 
be representative of Mfb microevolution in a high prevalence setting. In addition, the 
congruence between spoligotype and MIRU data provides further supportive evidence of 
a clonal population structure for Mtb. 
There is accumulating evidence relating differences in virulence beween strains in animal 
models to the interaction with the host innate immune system. It has been suggested that 
the W-Beijing lineage of clinical isolates is more virulent in animal models(l6; 122). In 
our study we did not find an association between broad strain lineages such as W-Beijing 
strains and a propensity to cause extra-pulmonary disease or meningitis. We chose extra-
pulmonary disease and meningitis as our outcome measures, since these were common, 
are easily defined and represent a clear spectrum of disease. It is possible that the use of 
alternative measures of disease severity might reflect more subtle differences between 
strains . In addition, these result should not be extrapolated to adult tuberculosis, where 
the strain distribution of extra-pulmonary cases may be different. Indeed , Kong and 
colleagues( 114) found an association between extrapulmonary disease and W -Beij ing 
strains in adults. 
There is considerable diversity within strain families based on MfRU-VNTR and , more 
recently, deletion analysis. Tsolaki et ale 179) have defined large deletions resulting in 
considerable genotypic diversity in 100 clinical strains of kltb as well as deletions which 
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The burden tuberculosis in Western South is 
in the In incident cases exceeded I ( 037 cases 
per I ind There were more cases of 
Town in 2005 than in the entire United States. Town 
ly In 5 years a 
a concurrent HIV 7.1). The reasons these 
rates are unclear the one of the richest 
and has a lower HIV than many other sub-
7.1 The of active 100000 













outcome of with from a interplay of host, 
environmental and bacillary factors. In previous chapter we have that the 
major families in the region to two broad ... _'_,...,_'~, the 
(the major rpnrp<opnt<ltnJP of which is the 
1 family [LAM3]), l"('\nnrYYl the of others in 
fieJd(1 180). 
The family strains is globally distributed(127) and well documented as a 
cause including cases, in HIV-
.nT'~l"t.'rI individuals( 131). strains have recently been "Vv'''''''U with extra-
been associated thoracic and with HIV intection( 142). vaccine 
with relatively poor protection against strain in 
experimental models( 152). In W -Beijing strains have demonstrated to be 
has virulent in animal models(l9; 181). The increased 
attributed to production of a phenolic glycolipid which is able to the innate 
16). More W-Beijing have shown to have 






are no unambiguous data human demonstrating 
virulence. 
marker ""·r,..,."",, virulence be the ",.OPrI['(> or 












W-Beijing strains were emerging in Cape Town. We the proportion 
Beijing children nr"'<:PI,t to Cross Hospital annually over the 
short term trends and to determine the proportion ofW-Beijing 
recently transmitted cases. we typed in archived 
histological in order to determine a In emergence of W-Beijing 
In Town. In 
responses was a conserved 
to whether the ability to subvert innate immune 
"'nr,nrr'". ofthese strains, we evaluated cytokine induction 
by current clinical in a primary macrophage model. 
Methods 
7.2.1. Sample 
7.2.1.1. Culture 1solates/rom Red Cross Children's Hospitlll: 
Over the period 2000-2003 we collected all cultures positive for lvltb children 
presenting with tuberculosis at this hospital, as described in the previous chapter. 
7.2.1.2. Arcllived histological specimens: 
We obtained a 
76-year time period (1 
selection of post-mortem tissue samples from each decade over a 
to 2005) from patients who had with active tuberculosis 
the archived collection in the Division Pathology, Groote Schuur 
Hospital, Town, South Africa. Groote Schuur Hospital is one two tertiary 












from tissues HIV -negative at time autopsy. Prior to ] 995 mv was 
not 100 who had died with were selected for 
each u .. ,'u ..... 'v, permitted. Demographic including age, gender, and 
were recorded patient. were obtained from lung 
extra-pulmonary sites selected if affected lung tissue was not available. 
Following selection, companion haematoxylin 
confirm evidence of tuberculosis infection. 
eosin stained were reviewed to 
with of ' old 
or in which we were to the diagnosis of tuberculosis were 
7.2.2. DNA extraction 
Following of tissues, twelve 7fJ.m specimen tissue were cut and two 
Extraction into each of <:Pt",;lr;lTP 2.0ml "r.rpw_. 
mycobacterial DNA was performed a method 
on use of 00 (Bio-Rad, Marnes la ,,,\,,\p'nH'l1 in 
the spol manual, (Appendix C). 150fJ.1 of a 5% ~""""",l 00 
suspension was added to a micro tube containing the tissue mixture was 
heated to IOOoC in a water-bath for 30mins and subsequently centrifuged 1 Omins at 














This was as previously described(99), details in Appendix C. W-Beijing 
are identified an spoligotype with spacers 1-34 
absent and 35-43 present. We v.u,""u,,, .... our spoligotyping to 
foJlowing spacers J -34 and presence of at least 
1 spacer the 'W -Beij ing': absence of spacers J -34 and presence 
spacers 35-43 'Euro-American'(J u~"'''''''_v of '''';''1'.'"'''''' and of 
this 'Non-Beijing Other'; presence of multiple spacers 
between] non-W-Beijing), where ""'CIf'P1"" 33-36 was not clearly 
and or no to aMtb 
strain(94;J03,J55). We chose to use broad "Euro-American" than 
a to spoligotype 
in many cases patterns were incomplete and would not allow 
7.2.4. Quality control measures 
A number of were to prevent cross contamination. a 
was cut '"'pt'",,,,>,, 
The the work 
area wiped down 10% in preparation for the next "U"'OJ"~' The 
were for quality control III process: 












fast with Ziehl-Neelsen ""''''''nf,,,n control tissue: a tissue ",p('tlrm without 
any of tuberculosis infection or extraction batch control: a suspension 
00 in an tube processed in same way as samples (but with no tissue) to 
ascertain that the was contamination free. 
Additional precautions were to avoid and detect contamination the 
post-PCR product nrr,,'pli"rpc were 
conducted in laboratories on separate days. Positive and negative tissue controls 
were included during DNA extraction and genotyping. All work areas were wiped down 
with 10% bleach and all procedures were performed wearing clean 
A :>UI.vIV:>:>lU 
with 




In order to obtain an 
necessary to repeat DNA 
spoligotyping on 
Single Nucleotide Polymorphism (SNP) analysis 
result for an 
or 
In to confirm we and "...,~.u,,""".u a 91 base pair 
of Mtb DNA to detect the presence of a discriminatory SNP(96) at position 
4280708 (H37Rv) from all 13 
selection of 56 samples in which 
strains contain an adenine 
in which and a random 
strains were identified by spoligotyping. 












position. following pair was . forward r<r<'T"T'.'-' 
(H37Rv 4280682-4280699), reverse (4280772-
The was purified and cycle was performed (reverse 
only). 
7.2.6. Macrophage infection model 
We selected representative 





of two sub In Town(140). The 
strains vw",.., .. ". were clusters defined 
MIRU-VNTR analysis of the strains. strains were used evaluation 
growth rates and 6 strains for evaluation cytokine induction (equal with 
RD t 50 deleted or not 
MDMwere 
and 7 donors 
from healthy blood donors (5 donors 
cytokine assays) and isolated, characterized 
growth assays 
infected with W-Beijing 
strains or H37Rv exactly as previously cf'r.hpr! (Appendix D)( 182). were infected 
at a multiplicity of infection of 1: 1 4 hours, followed by washing 3 times in warm 
RPMI to remove non-phagocytosed Wi Ikinson et al have previously shown the 
washing procedure ensures that -90% bacilli subsequently recovered from cultures are 
cell associated rather than in the supernatant(l83). To determine rate of Mtb nrr,u!1rh 
in cells, colony forming units (CFU) were determined at time 0, 3 and 7 d after infection; 












water followed serial dilution and plating on to 1 agar. cytokine assays non-
phagocytosed were not washed away from the 
in cytokine production between cell 
initial uptake. 72 h incubation at 37 
in an attempt to 
be accounted 
culture supernatants were 
harvested and at Supernatants were for the 
presence of tumour necrosis (TNF) and interleukin-12p40 (IL 1 
antibody pairs from R&D Systems (Abingdon, UK). assessment growth 
rates induction 5 and 7 donors were used rpClnpr'T' 
7.2.7. Statistical analysis 
analysis was performed Software 4.0 (Graphpad 'VH,,,,,",rp and 
9 (StataCorp Non-parametric unpaired was analyzed 
Mann-Whitney U test. 
Beijing per periods. 
Fisher exact test was used to compare proportions of W-
sq uare for trend was to evaluate the changes in 
ethnicity, age and strain distribution over time. The Kruskal-Wallis test was used for 
comparing median ages. We used 'v".'~"~ 1".'0'1''''''' to controrfor the 
(measured as a dichotomous ethnicity on the between 
of age and 
either 
designated time period) and number of 
The Friedman test was used to compare cytokine induction by 
strains ide:ntiiied. 
and growth in 
Dunn's Multiple Comparison test was for post-test comparisons. 
Significance was inferred by p<O.05. Approval study was obtained from 













Strains currently circulating in Town 
To assess recent transmission strains in Town, we genotyped all strains 
Mtb cultured children at major regional I-'''''~'''''~''' referral 
Town (Red Cross 
children were obtained (6 
Hospital) over the period 2000-2003. 
isolates were in 
in Chapter of which 64% were from pulmonary specimens 
in 
29J 
1). The m~jority 




strains as a percentage 
as 




























7.2 Changes in proportion of strains amongst Mtb strains in 
The proportion as a of total (solid bars) 
proportion of strains with "V''''''''U as a all W -Beijing 
(shaded bars), amongst children with culture-confirmed tubercu.losis at Red 
Hospital 2000-2003 exact test for 2000/2001 vs. 2002/2003 
B. The proportion W -Beijing-positive ,,,,,,,n'v,,",,,,,, samples 
Mtb-positive samples) from post-mortem 
square test 
80 












with histological of 
p=O.OOOl) 
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Strains in archived histological samples 
To further whether the frequency of 
in the region, we fTP1"If>H;1'\Pf1 strains of Mtb nrp"pnt m 
strains had recently emerged 
post-mortem 
in which there was histological of tuberculosis over the period 1930-
2005. The numbers per decade were chosen: 1 
945 n=(78), 1 n=(65), 1 n=(55), 1 n=(52), 
1986-1995 ), and 1996-2005 We were able to obtain an 
interpretable pattern (74.7%) individual 
From 1930 to I none of 169 patterns were W-Beijing 
Between I 966 and 1 4 of 138 (2.8%) patterns were identified as W-Beijing. 
However, in the decade 1 to 2005 the pattern was in 9 
(20%) (Odds ratio 19.05 [95% CI2,45-1 p=O.OOOI comparmg 
the period 1930-75 1976-2005, 7.2B). By ""rYnVl, ... N,n the proportion 
strains declined the study (OR 0.79 [95% CI 












2. by time period 1) 
period W-Beijing Other Non-Beijing 
(%) (%) (%) 
0(0%) 28 (90.3%) 3 (9.7%) 
0(0%) 39 (83%) 8 (17%) 
0(0%) 39 8 (17%) 
1956-1965 0(0%) 34 10 (2 
30 (75%) 9(22.5%) 
33 10(22.7%) 
1986-1995 
1996-2005 33 3 (6.7%) 
Total 13 (3.71%) 274 (77.8%) 65 (18.5%) 
*Chi square comparison W-Beijing cases I 975 vs. ] 
19.05 (95% CI 2.45-148.3) 
W-Beijing", Le. all in which there 
present. to investigate 
igotype classification, we amplified a 
discriminatory in all W-Beijing containing and in 56 randomly selected non-W-
We were able to obtain interpretable sequence 
from J J of the 13 and 49 56 samples . In all 















demographic details patients are shown in Table 3. med was 33 
years (range years). The UJ~'''''''''' age of patients was lower in the earlier 
(p<O.OOO I), primarily performed during 





Table 3. Demographic 
Time 
excluding all cases (Odds Ratio 14.04 
l~ for comparison the periods 1930-1 and I 
of patients 
I Ethnic background no. (%) 
Median age Percent 
7 
n Black Cape Unknown 
period 
i 
years (range) female European 
African Coloured* 
1930-1935 45 3.0 (0.3-55.0) 57.8 5 (11.1) 32 (71.1) I (2.2) 
1936-1945 78 11.0 (0.3-69.0) 46.2 .10 (13) I 51 (65) ] 5 (19) I 2 (2.5) 
1946-1955 65 5.0 (0.3-69.0) I 41.6 16 (24.6) 34 (52.3) I 13 (20) 2 (3.1) 
1956-1965 55 33.0 (0.3-93.0) 49.1 23(41.8) 27(49.1) 4 (7.3) I (1.8) 
1966-1975 52 40.5 (0.4-75.0) i 42.4 25 (48.1) 24 (46.2) 3 (5.7) 0(0) 
1976~1985 56 44.5 (0.8-77.0) i 48.3 29 (51.8) 20 (35.7) 7 (l2.5) 0(0) 
1986-1995 71 52.0 ,,_)'<<1 43.7 42 (59.2) 281'(39.4) 1(1.4) 0(0) 
1996-2005 49 43.0 (18.0-82.0) 51.0 28 (57.2) 20 (42.8) 0(0) 0(0) 













Ah"",.,,,pr\ a change in ethnicity of subjects Do;st-Illortems with an increase 




p<O.OOOI). However we aetlecH~a no 
group and strain type Crable 4). 
regression to control for the effects of age 
predictor of the emergence ofW-Beijing 
1, the comparison ofthe period 1930 to 1 
eXIJressed as an increase in odds per u""auv, 




(OR 16.54, 95% 












ofW-Beijing strains by ethnic group 
W-Beijing Other strains Odds ratio 
(95% CI)* 
I (1.0%) ] 02(99.0%) 0.51 (0.05-5) 
1.43 (0.31-6.64) 
3 (I ] 5 (83.3%) 
Total Black African 7 (5.4%) 1 (94.6%) 1.63 (0.54-4.98) 
(0=130) 
Cape Coloured 6 (3.4%) 172 (96.6%) 
* Odds in favor of Black 
interval) 
a strain (95% confidence 














5 donors) and to induce the 
TNF (6 strains in 7 donors). 
differ significantly from that 
except for a single 
7 
to determine the ability of a representative 
to multiply within macrophages (4 strains in 
cytokines 1L12p40 and tumour necrosis factor 
strains within macrophages did not 
rpt."r""n"", strain, H37Rv (Figure 7.3A) 
at day 7 (p<O.05). lJIO"lJlIllO similar rates 
growth than H37Rv 
strains induced 
less IL 12p40 (p<O.OOO 1) and (p<O.0007) (Figure 7.3B, 
C). There was no in rate or "'!T'r\V'1n 
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H3 7R V RXH24 RXH65 RXH 169 RXH360 
Il 
..,. co 00 '" 7. N ~ ~ ;f, ~ I N ,-. X I I :r: :r: 
"" ~ ;;! X a: "" 
W·Beijing s tf<tillS 
c 
~ '" ~ 00 ~ 00 c Z N -.:> ~ '" -.:> r- :r: :r: I :r: I i :2 x A 
"" a: X X X X "" "" a: "" 
W-Beijing Slra ins 
A. Intracellular growth of strains was 
similar, with only strain RXH 169 
showing a significant increase in growth 
compared with H37Rv on day 7 
(p<0.05). Error bars show median and 
maximum; 
B. IL 12p40 induction by strains. W-
Beijing strains all induced less ILI2p40 
than H37Rv (p<O.OOO J, Dunn 's post test 
showed p<0.05 for RXH65, RXH278, 
RXH 169, RXH360). Median and 
interqual1ile ranges are shown with 
error bars showing minimum and 
maximum. 
C. TNF induction by strains. W-Beijing 
strains all induced less TNF than 
H37Rv (p=0.0007, Dunn's post test 
showed p<0.05 for RXH65, RXH278) . 













Mtb is slow-growing, rarely undergoes horizontal exchange(92) and most 
rise to unapparent infections, 
communities are 
in the population structure of 
here we present two 
Town and are rapidly 
in nAct_''Y'IArtpWI specimens from 
century, appearance being in 
emerged as a major cause of 
we observed that the proportion 
of Mtb have recently 
were rare or 
part of the 
In the last decade however, 
strains amongst children 
>4U""""'{1 with tuberculosis increased from 12.5% to 32.8% over the period 2000-2003 at 
to 
referral hospital in Town. 
An"p .. ,,,pn independently at 
80) and is therefore likely to 
in children is almost always due to n,'r,,,"!'''''''' 
the current extent of transmission 
contrast, our evaluation of strains present in 
for 2003 coincides 
referral centre in 
of the region. 
primary disease, this 
strains. 
histological material did not 
a W-Beijing strain amongst the 116 children (younger than 10 years of 
in the period 1930-1965. Interestingly, a 
has an intercept at 1 which 
(1 obtained 
line drawn from the recent 












The younger age 
attributed to 
period. It may 
Chapter 7 
earlier years of study is undergoing 
number of children with meningitis during 
that this could influence our analysis, as certain may 




with meningitis, strains were still strongly over-represented in the 
This is in ~"''''IJl!J';::' with our previous work 





age in Vietnam( 1 W -Beijing may 10 region. 
In our age was not a predictor W-Beijing O'",.,onlrlP but may 
the small number of from children in the more recent uc;,.au.c;;:,. Given the 
high proportion strains in our paediatric collection, it is possible that our 
post-mortem may nQl~reS[llmale the magnitude of the emergence of these 
We ""","''';;,u to use spoligotyping as primary for identifying strains, 
as highly accurate for this "'''.a;::.''', 85) and is 
for use on degraded DNA. DNA in paraffin-embedded tissues is variably 
86) it is not UV.''''"lJl to npr1'nrl'YI multiple interspersed repetitive unit 
(MIRU) large sequence polymorphism analysis or 1S611 0 restriction 
polymorphism analysis on such specimens. aim of this was to 
determine whether ing as a whole were expanding in the region than 











There is recent "'11£1",(1"" of a group 'ancestral' strains do not 
the share a common ancestry 'modern' 
strains(l the 
emerged in Cape Town all have the characteristic 
strains which have recently 
deletion (we did not 
single strain with a spoligotype pattern compatible with In our 
collection), it is this 
histological material. 
that we 
Prior to European settlement of the Western Cape 
to identify in the archived 
400-500 years ago the 
population density of Khoi-San peoples was very low and tuberculosis was 
rare or unknown. European 
indeed, some years, 
is 
Cape was 





in the early of the 
This 
century 
with our of strains 
to the Buro-American .... __ ._,. which 
that the 
predominates in Europe. Admixture between East KI1Oi-San, European and 
African populations gave to the Cape Coloured population of the 
strains are common in East Asia. It was therefore surprising that 
strains were uncommon 





that strains have existed in isolated areas or at a low since 
Beijing strains are now common 
tuberculosis(140;174;188). 
Cape Coloured patients with 
184). W-
the 












This is the first study to document the emergence and expansion ofW-Beijing strains 
within a tuberculosis-endemic region over an extended period of time. Such a rapid 
change in the population structure of Mtb within a short period of time is unexpected and 
suggests that these strains may possess a significant selective advantage. 
Possible alternative explanations for the observed expansion of W-Beijing strains include 
migration, clonal spread and drug pressure. There has been no documented significant 
migration from Eastern Asia, Russia or Eastern Europe (where W-Beijing is prevalent) to 
the Cape Town region in recent years. Currently, the Asian population in the city 
constitutes 1.4% of the total population (Census 200 l, Statistics South Africa). Prior to 
the 20th Century there was little history of settlement by black African people in the 
Western Cape region. However urbanization and rural displacement saw increasing 
migration (which peaked in the 1940s) such that the African population now 
predominates in many areas(189). This is reflected in the shift in ethnicity of post-
mortem subjects over the period of study. This change long preceded the emergence of 
W -Beij ing strains and so internal migration is unl ikely to account for our observation. 
Moreover, there was no association between ethnicity and strain lineage on multivariate 
analysis. 
Previous reports have largely focused on clonal outbreaks ofW-Beijing strains in 
communities with a low incidence oftuberculosis(149). We have previously shown that 
the population structure ofW-Beijing in the Western Cape is heterogeneous, including at 











current in W-Beijing IS ",,.p·TA,·,,, not due to a clonal 
is a between strains and 
Marais and "Vllva.~U\_" described an association between drug 
resistance W-Beijing of Mtb in Town, however most W-Beijing strains 
(83%) were drug-susceptible(l80). Only 9% of the strains in our paediatric 
were to either ."v .... u~ or rifampicin the 
majority W-Beijing in the region fully 
not shown). 
this is to be 
most fV\,rT<:l'C'>T reason for strains, however drug-
may playa role in their expansion. 
There is of an mv infection and W -Beijing 
colleagues (2006) documented a association the 
W-Beijing and mv amongst with meningitis in 
of the 
primarily (86%) HIV-infected 
outbreak in New 
93). It is therefore 
City was 
that the 
emergence W-Beijing coincides with the of the HIV 
HIV was uncommon until 1994, when 
clinic first exceeded 1 %. then there has 
















used for study from HIV-uninfected persons (since full 
mortems are not npY'Tf'lrrn on patients), It is hprptArp not to 
from our data whether HIV has contributed to 
that an increased burden ofW-Beijing strains 
it is 
u •• __ ,_", persons, who 
presently account for 47% of tuberculosis in Town (Western 
data, unpublished), would over' into the HIV-uninfected population. 
Since HIV co-infection is associated with a rate to active 
more rapid onset severe illness( 194), rapid may be 
more likely in a population with a high is n  on 
proportion W-Beijing in other pal1s Africa. Since rates of 
infection are higher in the provinces, it will important to document the 
presence these strains beyond the Western province. 
Previous rp,v\rtc have that isolated clinical W-Beijing 




in 6 clinical 
Town. There was no 
the 
Ti'P"Pn/'p between the 
of prevalent in this (RD150 deleted and not 
of these strains to cause in the the apparent rlif'fpr,o.nr 
(Chapter 6). Interleukin-l and TNF were chosen as r~r;rp.,,~ pro-
been to in 
response to Mtb has that the ability 











of interleukin-l 0 producing regulatory T strains are to 
the 1"\ .. r.t",('·to immune response, which plays a key in maintaining 
latency(196), it is that a proportion progress to active 
rather than becoming latent. situation likely be co-
Immune may related to an increased 
In ',""Tlnn which 
lary load, as demonstrated in 
some animal models(19). my "''''C''"'''''''''_''' with 
bacillary burden( 197), may have a An 
lung may increase transmissibility (and may increase likelihood of 
to extrapulmonary reflected in the association hp1",,,' ,, and 
extrapulmonary tuberculosis(l ] 4). 
authors have that vaccination feasibly for the 
ofW-Beij strains(152-1 vaccination in South Africa in 
1973 and is now almost closely the period over which W-
L<'v" .... t:. strains have expanded. We any data 
W-Beijing with BeG 
7.5. Conclusion 
We have documented emergence and rapid within a 
suggests that these possess an 












occurred in context a concurrent cumulative impact of a 
highly "'U"',",I;;;I.-ILI host population and the rapid spread strains is to 






































of childhood tuberculosis which pose a particular 
use ELlSpot 
may a adjunct to 





""""""1'. to hospital with ;'U,HJI;;I;;l\;iU 
during early treatment and therefore 
a efficacy of therapy. Furthermore, 
we demonstrated that ofthe assay is 
disease in a community setting, where 
over TST. responses, but not 
in very 
not appear to 
with 
any 
responses were strongly age-
responses may age-related in A negative 
response should not be used to in young 
work is to confirm the ",nc'nl1"'nt nature 
to assay in HIV -infected 




tuberculosis in very young HIV-uninfected children, where the may 
Given'the considerable costs of this assay and the relatively poor performance 
its utility in resource-poor settings is questionable. 
In the second part of this thesis, we the question whether the outcome 
tuberculosis in children, in particular the propensity to develop extra-pulmonary tit"''''''''''' 
is by infecting strain. 
genotyping to ofMtb 
used a range of 












Town, and that the of were caused two Mtb 
namely W-Beijing and LAM31F11. U"'-'",;'-''' did not appear to differ overall in 
their propensity to cause extra-pulmonary in the were, 
however, shown to belong to two defined by sequence 
polymorphism There was an association npl'UIP,'n sub-lineage tuberculous 
with strains characterized by more likely to cause 
meningitis than without deletion. All were shown to 
possess a common immune-subverting phenotype previously described 
There was no distinction between strains and 
without the RD150, with to 
within human mClno,cy(e-o macrophages. 
biological for the in clinical outcome. 
work is 
induction or growth 
to determine 
In to further the preliminary observation that the proportion of W-
Beijing amongst presenting to hospital had in frequency over 
period 2000-2003, we genotyped strains of Mtb m 
who died with tuberculosis over a 76 year period. 
rpr'pntlu emerged in Cape Town, are rapidly W-Beijing 
This expansion that strains have a selective advantage, which 
may to their immune-subverting phenotype, their association with FIIV infection, 
or the effect vaccination. Future work focus on the 























Appendix A. 'In-bouse' enzyme-linked 
immunospot (ELISpot) assay 
1 Purpose 
To interferon-y (IFNy)-secreting T in response to stimulation with 
phytohaemagglutinin PPD Mtb-specific antigens and CFPIO. 
A.2 Principle 
method is based on Lalvani et aJ(48). A microtitre with 
membrane is coated with a monoclonal antibody to PBMCs patients 
with SDe(~tea tuberculosis are to the 
PPD, or 0) and 
individual T cells is detected 
Streptavidin alkaline is 
occurs representing the 'footprint' of individual 
with stimulating 















venous is a Falcon with nrp<.: ... rv". free sodium 
(1 o Jll/mi blood) or into a ",VI,,"l"l heparin tube (green top). are 
at room temperature and brought to the laboratory in a sample to contain any 
A.4 Reagents 
Mabtech kit lFNy HH'U'~,"'ll. Nacka, .'UtF'''F'n 
Alkaline Phosphatase USA) 
buffer: O.IM pH 9.6 
RPM I plus 
RJ 0 plus 10% Foetal Calf Serum (FCS)) 













1: Coating of plates 
Coating procedure is performed in the Class n Biological 
and 
a. Add 100111 of capture antibody (1 
coating buffer) 
b. and seal in cling film incubate 
A 
Cabinet to maintain 
lSug/ml in 
1:0 hours 
Day Blocking, preparing cell suspensions, washing and 
loading of plate 
preparation of cell suspensions, washing and 
in Class II biosafety cabinet 
a. Coating and once with 200fli 
RPMI). 
ofthe plate are performed 
solution (l FCS in 
b. dry on towel. Add 200fll solution to each well incubate 
for 2 at room or 1 hour at 
A.S.2.1. Separate and wash PBMCs: 
a. Heparinised blood is 
set in the 'low' position. 




is stored at 
]0 at with brake 












c. The remaining red cells are 1: 1 in and onto 5 ml 
histopaque. 
d. suspension is at 2400rpm 15 minutes with the brake set in 
'Off at 
e. The carefully removed with a 
in IOml PBS in a universal tube. Remaining 
lS and add to PBS/ceil 
f. is with and is centrifuged at 
1500rpm for 10 at 4°C. (lst wash). 
g. After centrifugation, the supernatant is decanted biocide and cells 
resuspended by tapping the tube. IOml 
is mixed centrifuged as 
PBS is added to the cell 
(2nd wash). 
h. Supernatant is carefully removed and discarded with a plastic Pasteur pipette to 
just above the cell button. 
1. ImlRlOis the mixed by and expelling 5 times. 
A.S.2.2 .• Red Cell Lysis: 
The mononuclear layer (after on FicoJl) can contaminated with 
red particularly in patients If this occurs, the following 
procedure is performed the first 
a. the by tapping the tube. 
b. 45ml ofRI 0 in a 50ml tube, 4.5ml + 40.5ml RPMI 
c. To the cell of sterile water and gently 10 - 12 times. 











e. Centrifuge as 
A.5.2.3. Cell counts: 
a Nunc 
sample: 
(this the place of the 
UVllVU",",U cell culture 
wash). 
prepare following wells per 
a. one well viability testing add 10111 1.8% NaCI 
add 20f,l1 of cell suspension, mix I. 
A 
b. To one for I count, add 40f,l1 2% Acid Methylene Blue 
to a 1 in 5 dilution. 
c. Fill2 chambers per patient (1 with suspension, 1 
cell count 
d. lOx objective to calculate the percentage vi bility (non-viable cells take up 
Trypan Blue 
e. Use 40x objective to count 
monocytes are counted. 
(all lymphocytes 
A.5.2.4. Preparation of antigens 
a. (positive 
f,lg/ml. 
b. (Evans PL00039/0439) 
c. 
concentration of 5 
all in RPMl): 
Cat. No: L-9134) 
and 
final ,"v"",,-,uu of 1 
11enmeultlcs MT ESA T6). 

















herape:utll;;S MT -CFPI 0). Require final 
e. Add to in 2ml round-bottomed tubes (Cat No.341 I 
f. 
g. 
sufficient duplicate wells (Table 1). 


















Table 1. Concentration and for assay 
PHA CFP-IO 
3xlO6/ml lxlO6/ml 
• Concentration lxlO Iml 3x1O Iml 3xlO 
cells 
Dilution of IOOI-t1 + 100111 
3xlO6/ml 200111 RIO 20011] RIO' 
Volume of 250 11 1 250 11 1 240111 200111 
cells 
Stimulant 50111 PPD PPD 10111 2.4111 
CFP-lO 
Volume 12011' 120111 105 111 100111 
well 
5llg/ml lOllg/ml 5J.1g/ml 2.51lg/ml 
concentration 
- ofstimulant 












Table 2. Plan 








120111 120111 ] 20111 
120111 120111 12°111 
The following controls are included: 
a. Positive control: Cell suspension PHA 
b. No control: Cl1C,",p''''If,n only 





d. Detection antibody control: RIO "'"''''''''''' .... of detection antibody 
(Note: Controls c. and d. are not necessary once assay is 














Day 3 (or 2 coating protocol was followed) 
a. The rest assay can now be carried out on plate 2 times 
6 times with with using multichannel 
filtered containing 0.05% Tween20. Dry on towel 








PBS (100111 in 20ml PBS). Dilute 1 in 1000. Add 100111 per well. 
room rp'n,u'\"'r<l,Ilt'P' 
6 with sterile 
on paper towel 
in 
Streptavidin Alkaline 
Add 100111 per well. 
in room temperature 
6 with sterile 
BIO-RAD Alkaline 
Prepare sufficient 
patients, I hour 
in 25 di lution of concentrated 
hours 
Tween20. 
1J"GIC"" ..... Dilute 1 in I 000 in 0.5% 
] Yz hours 
Dry on paper towel. 
Substrate kit 
development 
at room temperature. 
e.g., 4.8ml distilled water + 200111 
concentrated development buffer, add 50111 each of Solution A and B 
to 5ml development butTer immediately before use, mix well. Add lOOlll/well 
] 0 - ] 5 minutes in the 
reaction by 
Allow to air dry 












A.6 Interpretation of results 
The number in well is 
average of the counts 
is expressed per million 
two observers using a 
n""'OPY'JP'''' is calculated. number 




ppo: no spots to innumerable 
<10 spots per well 
on exposure or 
Negative 
A is indicated by a minimum 10 per well and at 
number in the 
translates to spot forming cells 
result is 06 PBMCs. An 
or o wells are positive by 
An average of 10 
per million PBMCs. 
assay is reported as 
criteria. 
Limitations of procedure 
If an individual's response to an is very strong, the spots are 
A around the rim of the well can obscure some spots 
counts. 


















A.8 Optimization of procedure 
was relatively to set up and The only problem was 
to introduce the red step in order to with PBMC 
significantly contaminated with red These resulted in indistinct spots 













Appendix B. T-SPOT.TB ELISpot Assay 






major TTplrpnrpc:: between in-house commercial assays are as 
blood mononuclear cell preparation tubes (CPT 
Becton are (according to manufacturer's 
the ofPBMC . 
. TB uses a commercially of 
peptides from -6 and CFPIO, than 
'in house' assay. 
includes ELlS pot with the IFNy 
antibody so a coating 
incorporates use a ete'CUCll1 antibody linked to an enzyme 
obviating the need for a c::p..,,..,.,..t,,, step in which avidin-peroxidase 
enzyme is 
cut-off value a positive test as specified by the manufacturer is 
in 
somewhat less stringent than that using the 'in house' assay: a panel is 
considered positive if the number of spots per well minus number of 
m background well is 6 or more (where the well had 0-5 spots) 
or if the number per well was than or equal to twice 












more A assay is ,."' .... tw·r"',., "'''''H''''''' if of 
peptides is 













Appendix C. Spoligotyping assay 
This method is that ~m,~rhl~f'!1C and colleagues(99) which adapted and 
described in a '''",,",'H''''V' manual (Isogen Biosciences, B.V.). details of the 
method as rlf'!s:~rilhf'!rI manual are summarised below. 
C.l 
To of Mtb in order to 
C.2 Principle 
is on DNA polymorphism "' .... '''·nt at the "Direct Repeat" (DR) locus, 
present in Mtb complex bacteria (Figure C.1). The consists of repeated sequences 
of36 interspersed by nl",_r""'p'titi'llP spacers, (each 3 5 to 41 base 
The DR locus in the genome tuberculosis H37Rv and M 















in the region results variable presence or absence of each of 43 
unique spacers. PCR is to amplifY the spacer regions primers directed 
the DR elements. The presence or ofthe spacers is detected by 
DNA to a set of immobilized 
oligonucleotides, replresem,mg each sequence. is able to detect 
presence or absence of each of these (Figure C.3). reverse primer is 
labeled so that the presence of each spacer can be detected by chemiluminescence 
Figure C.l Amplification of spacers within the DR region of M tuberculosis 
complex bacteria using primers directed against DRs (from spoligotyping manual, 
.... 
Orb 




















Figure lpt'>J"tl", .... of amplified products (from spoligotyping manual, Isogen 
B.V.)) 
Apply 
1<OlHte filter 90°, apr)]y bi()[iJ1-
labeled peR products ~Uld 
Reagents 
• Spoligtyping kit 
strain 
DRb one 
••••••••• • • •••••• ••••• • • • ••••• •• •••••••••• •••• ••• • •••••••• • •• • •• • • •• ••• ••• 


























• Detection rp"OPl,r RPN21 
C.4 Procedure 
(adapted 
extraction is ..,,,,.'t'rwtv> of 





a. Use a sterile swab to swab the surface a Lowenstein-Jensen and 
within a Sarstedt containing sterile water 
b. Heat 1 hour at BO°C to kill the and cool to room temperature 
c. 70 III 10 % SDS and 50111 proteinase K (10 mg/ml) on 
for 1 hour at low mode 
d. Add 100 ul 5M NaCl, mix thoroughly, followed by 100u11O% CTAB [N-
cetyl-N,N,N,-trimethylammoniumbromide], thoroughly 














f. Freeze (J 5 min at -70°C), thaw shaking 
g. Cool, add 700 III of chloroform/isoamyl alcohol (24: 1), 20 times and 
at room for J 0 min, 12,000 g 
h. Transfer 
isopropanol, 
Uy"",,,",V\.,, supernatant to a tube 
at 30 min 
L IS 
III 
j. pellet 80% ethanol and 
centrifuge 5 min at room 
k. Discard supernatant and dry pellet 
I. the in III buffer and store at 4°C until 
Preparation of Iysates from colonies or liquid media 
a. Resuspend cells in distilled water in a Sarstedt 
b. cells incubation at 80°C for I hour 
c. the tube at 13000 rpm 2 the 
pellet in 500 III of Ie water 
d. on high for 1 
Amplification of by 
a. PCR is performed on lOng purified chromosomal Mycobacterial DNA or 
neat lysates from heat-killed cultures 
use 
b. to required concentration. Include chromosomal 
DNA ofH37Rv and as positive controls. water as a control 


















II. 0.5).11 conc. 0.2 mM 
III. 0.1 ).11 
IV. 2.5).11 lOx 
v. 5).11 Solution Q 
vi. 1).1lof25mM (tinal Mg concentration 
VII. 11.9).11 water 
Add 23).11 per add 2 ).11 DNA template 
Cycling 25 
55°C; 30 sec by 5 min noc 
cycles) 






Add 150 j.11 
the 




to PCR products 
PCR product for 10 min at 
1 min 96°C; 1 min 
crude lysates use 
buffers 
and coolon ice 
d. Wash the 5 min at 60°C in 250 ml 2xSSPE/0.1 % SDS 
e. Place the Inf'mnrl'l and a supportcushion into so that 












f. fluid miniblotter aspiration. 
g. with product care not to cause 
and hybridize for 60 at 60°C on a horizontal 
h. the samples the miniblotter by and take 
using 
I. Wash the membrane in 250 ml SDS for 10 at 
j. the membrane in a rolling bottle and allow it to cool down to 
inactivation of the 
k. 2.5 to 10 ml 
add to rolling bottle for 45 to min at 
L the membrane in 250 ml of2xSSPE/0.5% SDS for 10 min at 
m. membrane with 250 ml 5 min at room 
n. For chemiluminiscent 
] min in 20 ml 
of hybrid DNA, incubate the membrane 
o. Cover the membrane with cling 
membrane for 10-40 
p. signal is too or too 
to expose another film for a 
expose a light 
the membrane can be 
or longer 
Regeneration of the membrane 
a. The membrane can used 10-20 














b. Wash twice 
buffer is 





c. the membrane in mM EDT A 8, 




controls and BeG) are a"'''''"",,,,,eu H37Rv 
BeG have spacers 3, 9, j 6 and 
control' should not show presence of any spacers. If the 
The presence or absence of each spacer (I to 43) each strain is 
temperature. 
have spacers 20-21 
aU"''''''H, The 'no 
the run 
and entered into 
an spreadsheet. is then to the Spoligotype Database for 
interrogation lineage 
C.6 Limitations of procedure 
Spoligotyping is less than methods used 
strains as IS611 0 RFLP and MIRU-VNTR)(l04). It is +h",.,,,Tr.~" 
where it is important to fI.T·t"r",.,t. between 
spacers may occur due to a 
recombination related may have very spoligotype 
11 is .... ".""".",, .. reproducible, rapid and ,p/'r,nl{' 98). 
Since the they may shared and to form 












identification major lineages of Mtb I'>Pl'"!,·po,,, spoligotyping, sequence 
and po Iymorphism analysis(96). 
C.7 Optimization of procedure 
There were no problems in the VP',''''l..,'''<lVl of the 
however following problems were encountered the course 
a. A of membranes v .... ,,'"''"' .... by Isogen not have spacer 32 
b. 
onto the We problem and produced a new 
batch membranes. 
problems were encountered in 
membrane. We identified the t"n"n,,,·,,t of the 
both the 
takes place were adequately nrf~-\J\illrlm 
regenerating the 
buffer as critical 













Appendix D. Mycobacterial interspersed 
repetitive number of tandem 
repeat genotyping 
D.I Purpose 
Second line following spoligotyping 
D.2 
The genome of Mtb 






size of the amplicon 
adapted 
40-100 base pair sequence elements known as 
(MIRU) which are found as tandem rpnl'51t" 
throughout the chromosome(lOO): These loci demonstrate 
leading to the use of the term "variable number 
is on the detection of the number of tandem 
iHp,rpnt loci. The most commonly used method 12 
the 
method is 
is performed by amplifying each of these loci, riP,.'''''''' 
the number of repeats at each locus( 100). 












amplifying 3 loci), fluorescently~labeled primers(1 01). of the fragments is 
was 
detected using an capillary sequencer. The method for this study 
on that of 
ABI3100 
01), which we modified for use on an Applied 
D.3 Reagents 
• HotstarTaq kit 203205 containing hot start Taq polymerase, peR 
Q) 
• dNTPmix 
• HiDi (Applied Biosystems) 
• Genescan-2500 standard (Applied 
• MapMarkerl 000 (Bioventures, Murfreesboro, USA) 












Table 1. Details for 12-locus MIRU-VNTR 
Mix Locus MIRV length Primers Label 
A 4 (a) 77 GCGCGAGAGCCCGAACTGC FAM 
CATAGGCGArrAnnrnAATAG I HEX 
40 (e) 54 GGGTTGCTGGATGACAACGTGT NED 
GGGTGATCTCGGCGAAATCAGATA 
IB 10 (a) 53 GTTCTTGACCAACTGCAGTCGTCC 
GCCACc I 1 uu fGA TCAGCT ACCT (F AM) FAM 
16 (b) 53 
:AGCCCTGGTAC HEX I 
31 (e) 53 ACTGATTGGC1JCATACGGCTTTA 
GTGCCGACu lLJU J C I J lJA T NED 
C 2 (a) 53 TGGACTTGCAGCAATGGACCAACl 
TACTCGGACGCCGGCTCAAAAT FAM 
~ 
23 (b) 53 CTGTCGATGGCCGCAACAAAACG HEX 
AGCTCAACGGGTTCGCCCTTTTGTC 
39 (e) 53 CGCATCGACAAACTGGAGCCAAAC 
iCGGAAACGTCTACGCCCCACACAT NED 
• 
D 20 (a) 77 TCGGAnACiATGCCCl I CGAGTT AG FAM. 
GGAGACCGCGACCAGGT ALI··I ufA 












27 (c) 53 TCGAAAGCCTCTGCGTGCCAGTAA 
GCGATGTGAGCGTGCCACTCAA 
MIRU 4 reverse 







Amplification of 1.'.1 ,'L ..... 'I..) loci 
a. PCR is performed on 10 ng purified chromosomal Mycobacterial or 
DNA extracts from lysed 
b. Dilute DNA to the Include chromosomal 
DNA ofH37Rv and as positive water as a control 
c. 2) 
d. To master mix tube, add 1 !!! DNA template 

















Table 2. PCR master for MIRU-VNTR 
Mix A (f.LI) Mix B (f.LI) Mix C (f.LI) Mix D (f.LI) 
Taq (5 U/f.LI) OJ OJ 0.1 0.1 
Solution Q 5 I 5 5 5 
dNTP (finaJ 0.5 0.5 0.5 0.5 
concentration O.2mM) 
lOx PCR buffer 2.5 2.5 2.5 2.5 
Primer (a) F&R 0.2 0.5 0.5 0.5 
Primer (b) F &R 0.5 0.5 0.5 0.2 
• Primer (c) F&R 0.5 0.5 0.5 0.5 
MgCh(25mM) 1.5 0.5 ] 0 
Water 11.9 ]2.4 11.9 12.9 
of fragments 
a. water 
b. For multiplex is mixed with 
Genescan-2500 Rox size or 0.2~1 MapMarkerlOOO 
formamide 
c. Denature for 2 minutes at 
d. Run on AB13 100 40 minutes using dye set D 
e. Calculate Biosystems) 












Table 3. Fragment at each 
No. of MIRV MIRV M1RIJ MIRV MIRU MIRV M1R1J MI~ MIRV MIRV MIRV MIRV relleats 02 04 10 16 20 23 24 26 27 31 39 40 
0 402 17< 482 565 437 150 395 285 498 492 540 354 
I 455 618 514 200 447 336 551 545 593 408 
2 508 671 591 253 501 387 604 646 462 
3 561 643 724 668 555 438 657 "16 
4 614 483 696 777 745 609 489 70 
5 667 560 749 830 822 412 663 540 624 
6 720 637 802 883 899 465 717 591 I 816 810 858 678 
7 773 714 855 936 976 518 771 642 869 863 911 732 
8 826 908 1053 571 825 693 922 916 964 786 
9 879 744 0 
10 /J" 795 4 
Il 985 1022 1067 1148 987 846 1123 948 
12 1038 1099 1120 1201 1361 783 1041 897 1134 I 1128 1176 1002 
lJ 1176 1173 1254 1438 836 1095 948 1187 1181 1229 I 1056 
i 
14 1144 1253 1226 I 1515 889 1149 1240 1234 1282 1110 
15 1197 1330 1279 942 1203 I 1050 1293 287 1335 1164 
• 
D.S Interpretation results 
ofMIRU number) at is expressed as a 
0-9. The MIRU-VNTR of the is {,,>rIA"'" by a 1 











locus 4). These are submitted to the International Spoligotype and 
database. 
D.6 Limitations of procedure 




our (all of which 
the W-Beijing 
same spoligotype). This ·,u"U'~'Y 
identified in 
thprpt'r .... " suitable 
for epidemiological investigations as well as to discriminate the major 
within each 
shown to correlate 
cluster. However, MTRU-VNTR has 
poorly with phylogenetic analysis conducted 
been 
single 
polymorphism anaJysis(96), and is probably not sufficiently 
the global of Mtb. This may to the potential for 
gain or to the possibility of convergent 
acquiring numbers at most 
D.7 Optimization of procedure 
The method used was that by Supply et 01). Several modifications 
were to the published method: 
Conditions 
a. The 4 reverse primer was changed to CAGCAGAAA 












b. reaction volume was reduced to III (for economy) 
c. peR COll01lnOllS were changed to amplification longer fragments 
and extension were increased) 
d. Primer concentrations were altered in A MixD, was 
preferential amplification of 
'''''''UU'.i''. to poor 1n to improve 
of longer the following in concentration were made: 
i. ]n mix A, locus 4 were at 0.16J.lM 
reaction) vs. OAIlM (0.5 III per other primers 
ii. In primer primers for were used at 0.16J.lM (=0.21l1 
reaction) vs. (0.5 III per reaction) other 
D.7.2. Genotyping on the ABI 3100 
method of Supply( I 0 I) was adapted use on the ABI31 00. involved initial 
dilution of products I in 70 in water this system is more sensitive). A was 
also fl'om Rox2500 to MapMarkerl 000 standard, had 













in order to approximate physiological The rates of crrryulth 











• 25ml screw cap bottles 
• 2m 1 Sarstedt 
Macrophage isolation and culture 
.. 50mi 
• 10,25 ml 
.. Coming 

























Establishing mycobacterial stocks 
a. Grow the (O.D.600 0.7-1) in Middiebrook7H9 
broth with ADC, and at 37°C with 
(120rpm) 
b. Freeze in 1 ml aHquots in concentration 15% glycerol (add 500 !!I of 
culture to 500 !!l of30% glycerol in water) in 2ml screw cap tubes 
c. Freeze at -80fiC 
d. After at 24 hours, to perform 
CFU analysis 
a. This is np,'1"r..·t'YI"n on to content as well as on 
to determine "''''''ITn 
b. agar plates by 25-30ml 7HI1 agar (with ,,-"'-''-
and 
to 
to each square dish (pour in laminar flow ""UJlIl'''' Allow 
and cool before .·",h"rY", .. ~ti 
c. content 
I. square agar plates (4 
incubator to warm 

















Ill. add 45111 sterile water to appropriate wells to determine 
content of add water to the first two rows A, 
plate) 
IV. vortex Mtb stock sure that lid Sarstedt is 
closed and vortex is placed within un .. '"'''''''' cabinet) 
v. add Sill of Mtb to each duplicate in row thoroughly 
(at 5 times with 40111 volume) 
transfer 5111 to row B for each mix thoroughly 
vii. _ ....... ,.,_ tips, 
viii. repeat 
to 10-6), 




ix. transfer I relevant (e.g. if 
need to 
out 
stock use }O'4, 10-5 and I dilutions) in to 
appropriate on 7Hl] 
x. not needed) for 2-4 weeks. Check daily after 1 
week 
xi. count colonies under lOx (using stereomicroscope) 
when colonies visible 
Monocyte-derived macrophage isolation and maturation 
a. Obtain buffy coats from SA Blood Services. need to be 
requested previous day. 
b. Dilute 12-15ml buffy coat to 35ml with RPM] in as many tubes as required 












d. 20 minutes 
e. 
at 2400rpm 
PBMC with plastic Pasteur and collect 2 tubes of 
50 ml RPMI per Ficoll tube 
t: Wash (spin at 1 for 10 decant resuspend in 
and pool into 1 
g. Wash and resuspend in RPMI 
h. 600-800 x 106 per 
L in large tissue culture flasks (I at 300 x I per 25 ml 
RPM} per for 2 hours at 
j. Pipette out non-adherent cells with 10ml pipette 
k. add 10mi warm RPMl to the (squirt on upper wall, not on 
cells). flask fiat and tilt. Stand it up and remove the RPMl. 
I. Repeat 2 more times 
m. 1 Oml cold refrigerate 20 minutes 
n. Using long-handled scraper, scrape the monocytes and pool in 50mI tube in 
PBS 
o. resuspend in 1 RIO 
p. Count, resuspend to concentration of 1 x 106/ml in RIO 
q. Plate out (l x I per well in flat bottom culture plate) 
r. Incubate for 6 days at 
may infected with 
in CO2 incubator, after which 
Prior to infection, ensure that 
macro phages 
look 
healthy by visualizing under microscope for plump some 




















1.'1'''1''1<1,'''' dilution of 
so CPU 
in warm RIO 
1 x 1 If 
assays, non-inactivated serum should be used 
enhance opsonization phagocytosis. 
aspirate of media 
to 
include H37Rv as 
relevant weBs 
control 
Incubate (37°C in CO2) as required 
analysis is performed, wash 
i. Aspirate 
ii. Gently wash 5 with warm RIO 
iii. Re-incubate for time period 
E.5.4.2. of macro ph ages 
is np'·rA'· ..... '.r! in order to to 
I. At relevant 
ii. Add 1 ml of 0.1 % to lyse 
Leave for 10 to allow 
v. Immediately n",rTr.,-m dilutions and 
E 
on prior CPU analysis) 
... "'· ... A'·.-.-.<." for " .. 'V""" 
making up RIO, to 
culture and add 
o as a 
4 hours 
()c .. A'utth rate in 
to occur 













a. At the relevant time aspirate supernatant cultures 
b. through O.22!Jm and aliquot tube 
c. at -80°C until use 
d. (lL-12p40, [3, IL-] 0) 
e. R&D DuoSet systems used exactly as manufacturer's 
f. or IL-12p40, o use neat supernatants, use 1:10 and [3 use 
1 :20 dilutions 
g. ELISA dilutions see 1. 
190 
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E 
1. ELISA 
capture Ab I wash block buffer reagent I detection I substrate stop I top standard 
solution 
dilution buffer diluent Ab dilution HRP dilution solution 
I.L12p40 I 61.1ul in 0.05% 1% BSA in PBS O.l%BSA, 61 lui in 55ul in Ilml 1:1 Colour 2N 
Ilml PBS Tween20 in with OO'i%NaN .• t 0.05% Ilm!RD RD Reagents for 




TNI<' 61.1ul in 0.05% 33ml RD per plate I%BSAin 61.1ul in 55ul in Ilml 1:1 Colour 2N 
llml PBS Twecn20 in PBS IlmlRD RD R<;;i:!g<;;lH~ 
















Interpretation of results 
CFU the of in human MOM is calculated, expecting roughly one 
doubling every] to 2 
low to undetectable «I 
and IP, with low «500pg/ml) and IL-IO. H37Rv and 
oflL-1 
1551 should 
induce levels induced by clinical strains 
vary. 
Limitations of procedure 
of cultures: clinical strains of Mtb is not 
Cli n.ical grow at very different some very so that 
is exhausted to achieving 00 0.7-1. For strains, subculture during 
early phase to new media should be performed to enhance "rNa,." Clumping is also a 
problem. addition ofTween-80 to media is helpful. ]n cases where 
clumping occurs, should briefly centrifuged 
tube to inoculate a new tube of media. Media should 
subculturing. 
clear at the top 
prewarmed prior to 
Monocyte isolation and maturation: There is variation from donor to donor in 
quantity and quality of monocytes Where numbers monocytes are 












be If more or confluent monolayers ofMDM are not obtained 6 days 
maturation, shou Id not used for with Mtb. 
is an in vitro model which, in many ways not nt'P'cP'" physiological infection, 
e.g., cells are infected in isolation, none of the components of the immune 
(e.g. mediators) nTP'CPtlT 
Optimization of procedure 
optim related to the growth of clinical strains of Mtb as noted above 
The monocyte and was an assay which 












Appendix F .. Large sequence polymorphism 
analysis 
F.l Purpose 
To of Mtb to distinct ... __ .,..,_~ (in the 
strains circulating in Town 
to 
to that the 
LAM3!F1 J of strains is monophyletic). 
F.2 Principle 





and all descendants 
are 
by et al(1 09) and VUl',j"~U et aJ(1 
the 
implication is that if a 
horizontal "'''~''jajjl'.'' 
and dup/ication(93). 
of Mtb, this region can not be re-




are known as 











used in on use of real-time 




ribosomal subunit) and a 
1""",D"tr\,pnt acts as 
an lnTP'rn" positive the failure to the 
implies particular the 
ete(~ted usmg presence of 




is presence of 
products on Applied 
in Chapter 6. 
• Primers and (for RD181, RDJ 50 and RDl42 as described by 
Tsolaki(109); for RD76 I these were 
2.0 [Applied Table 1) 
iII1 Taqman Universal PCR Master Mix (Applied 
iII1 Water molecular biology (Sigma) 
iII1 HotstarTaq kit (Qiagen 203205 containing 
buffer, MgCb, solution Q) 
iII1 ermlemas RO 192) 
using Primer 
start Taq PCR 
195 
University of Cape Town
Appendix F 
Table 1. Details of LSP regions and relevant primers and probes 
LSP or Start of Elld of Size Gelles L primer R primer Pl'obe or product sizes 
cOlltrol RD' RD deleted 
RD142 1332182 1335033 2,851 Rv1189- CGG CAA GAT CAC AAA AA T CCA CCC GTA ACG GGT CCA ATG T FAM -TCT TAG TGC AGC CIT C 
Rvll92 
RDl50 1896862 1899349 2,487 Rv1671- TGC TCG GTG GGC AAC TG CGG CAC AGC GAG ACG AA FAM-AAC GAC ATC CAC GCA IT 
Rvl674c 
RDI8! 2535429 2536140 711 Rv2262c- CGCAACGGCCGCGGTGAACTCT CGGGCGGCTGCGGGAACCTT Expected fragment sizes: H37Rv 
Rv2263 1712bp, if deleted 100bp 
RD76! 1502787 1503881 1,094 Rv 1334- GCCGGCGTGCTCAATGCTCAG CCTAGGCCGGCGACGAAGTGC Expected fragment sizes: H37Rv 
Rvl336 137Ibp, if deleted 277bp 
16S N/A N/A N/A N/a CGT TCC CGG GCC TTG T AC CGG GTG TTA CCG ACT TTC ATG VIC-CAC CGC CCG TCA CG 
rRNA 











F.4 Test samples 
chromosomal DNA Appendix B) from children 
to Red Children's Hospital (Chapter 6) 
Procedure 
F.S.l. TaqMan real-time peR RDlS0 and RD142) 
F.5.l.l. Master mix (per reaction) 
III I III genomic DNA 
III 0.25111 primer RD-F 
III 0.25 RD-R 
III 0.5111 probe RD 
III 0.25 III primer I 
III 0.25111 primer 16S-R 
III 0.5111 probe 16S 
III J Taqman 2x Master Mix 
III III water 
F. 5. 1.2. Reactioll conditions (Universal cycling conditions/or 
2 minutes then 10 












peR for RD181 and RD761 
Master mix (per reaction) 
• 0.1111 HotStarTaq 
• 511] Q 
• 0.5111 dNTP 
• 2.5111 buffer 
• 1 RD-F 
• I III primer RD-R 
• IIlI 
• 1.5111 
• 12.4111 water 
DNA 
(2SmM) 
F. 5. 2.2. Reaction conditions: 
Appendix F 
• Initial 95°C 15 min followed by cycles of denaturing 
annealing 1 :30 min; extension (for RD181) or (for 
) I :30min and final termination 10 min 
F.5.2.3. Agarose electrophoresis 











F.6 Interpretation of results 
time peR detection For each strain, product be clearly detected for 
a failed reaction. The 
some amplification 
positive is no I product 
water control should show no except in 
may be detected. The "'V~'''''''_''' of product for the 
I 6S of the same is as showing that 
gel 
product (for RDl or 1 
-no 
product (for 
deleted lOObp product with RD 18 J peR; strains 
with RD761 peR 
Limitations procedure 
presence will 
111 presence of 
relevant deletion has 
positive control 171 
with RD181 
1 deleted - 277bp 
an identical pattern 
real-time peR detection 
and is unlikely to 
is likely to be a rare occurrence 
influenced 
F.8 Optimization of procedure 
Tagman 
on universal 
uncomplicated and ur/O,."",,, 
robust and 
the initial set 
no particular 
181 and 
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